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1. INTRODUCTION 
1.1 Analytical chemistry (Kamboj, et al., 2003) 
Analytical chemistry deals with various analytical methods for determining 
and estimating different matters in various states. It is based on the various rings and 
functional groups present in a molecule. The Analytical chemistry has been split in to 
two main types  
 Quantitative Analysis 
 Qualitative Analysis  
Quantitative analysis gives the amount of the analyte in the component 
mixture. Qualitative analysis gives information about the various functional groups 
and rings in the analyte molecule.  
 The analytical methods are of two types 
 Classical methods  
 Instrumental methods 
 In classical methods, for qualitative analysis, the analyte is extracted and 
treated with the reagent specific for a functional group to give a coloured reaction. In 
quantitative analysis, the amount of the analyte in determined by titrimetric method or 
by gravimetric method. 
 The instrumental methods are based on the physical properties of the analyte 
such as the light absorption or emission, conductivity, mass to charge ratio, 
fluorescence, adsorption and partition etc. The instrumental methods are basically 
categorized as follows 
1. Spectroscopic methods 
2. Chromatographic methods 
3. Electro analytical methods 
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4. Thermal methods 
5. Light Scattering methods 
 The instruments used for the instrumental methods basically consist of a 
source, system under study and the response. The source may be a light source, 
electrical source or heat source etc., as required by the instrument. The system under 
study is the analyte under study or any physical character of the analyte. The response 
is the unit in which the analytical signal from the analyte which is converted to an 
output signal for the interpretation. 
1.2 Analytical Techniques  
(Douglas A Skoog, et al., 2004; Willard, et al.,1986; Sethi, et al., 2001) 
I. Titrimetric methods: 
A) Acid – Base Titrations 
1. Direct Titrations 
  a) Titration of an acid by a base 
   i) Titration of liberated acid 
   ii) Sorenson – Formol Titration 
   iii) Non – Aqueous 
  b) Titration of base by an acid 
   i) Titration of metal salts 
   ii) Non – Aqueous 
 2. Residual Titrations 
B) Precipitation Titrations 
C) Redox Titrations 
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II. Gravimetric Methods 
 i) Weigh drug after extraction 
 ii) Weigh a derivative after separation 
 iii) Weighing residue after ignition 
III. Spectrophotometric Methods  
 i) Dye complex methods 
 ii) Colourimetric method 
 iii) Ultra violet method 
 iv) Flourimetric method 
 v) Flame photometry 
 vi) Atomic absorption spectroscopy 
 vii) Infrared spectrophotometry 
 viii) Raman spectroscopy 
 ix) X-ray spectroscopy 
 x) Mass Spectroscopy 
IV. Electro analytical methods 
 i) Potentiometry 
 ii) Voltametry 
 iii) Coulometry 
 iv) Electrogravimetry 
 v) Conductance techniques. 
V. Chromatographic methods 
 i) Thin layer chromatography 
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 ii) Paper chromatography  
 iii) Column chromatography  
 iv) Gas chromatography 
 v) High Performance Liquid Chromatography 
VI. Miscellaneous methods 
 i) Thermal analysis 
 ii) Kinetic techniques 
 iii) Enzyme assay 
VII. Hyphenated techniques 
 i) GC-MS (Gas chromatography – Mass spectrometry) 
 ii) LC-MS (Liquid chromatography – Mass spectrometry) 
 iii) GC-IR (Gas chromatography – Infrared spectroscopy) 
 iv) ICP-MS (Inductively coupled plasma – Mass spectrometry) 
Factors Affecting the Choice of Analytical Methods (Mendham, et al., 2002) 
 The type of analysis required 
 Problem arising from the nature of the material 
 Possible interference from components of the material other than those of 
interest 
 The concentration range which needs to be investigated 
 The accuracy required 
 The facilities available 
 The time required for complete analysis 
 Similar type of analysis performed 
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1.3 UV SPECTROSCOPY (Sharma, et al., 2007; Gurudeep R Chatwal, et al., 2009) 
 The UV spectroscopy is one of the most widely used instrumental analytical 
techniques for the analysis of pharmaceutical products. The UV region extends from                  
190 nm to 380 nm. The instrument used to measure the intensity of the UV radiation 
absorbed or transmitted is known as the ultraviolet - Visible spectrophotometers. A 
molecule can absorb the UV radiation only when the energy of the radiation similarly 
to the energy is required to induce electronic transaction in the molecule. 
 1.3.1 Laws of absorption 
 When a beam of UV light is allowed to pass through a substance which 
absorbs the UV light, the intensity of the transmitted light is lesser than the incident 
light. The reduction of the intensity is may be due to 
 Reflections on the surface of the cell 
 Scattering of light by macro molecules 
Absorption 
The two important laws which govern the UV spectroscopy are the Lambert’s 
law and Beer’s law. Lambert’s law states that the intensity of the light decreases 
exponentially with decrease in the thickness of the medium through which it passes. 
Beer’s law states that the intensity of the light decreases exponentially with increase 
in the concentration of the absorbing substance. 
 The two laws where combined to form the Beer-Lambert’s law, which is given 
by the equation 
    A = abc 
Where, A is the absorbance 
 a is the absorptivity 
 b is the path length 
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 c is the concentration. 
 The absorptivity is defined as, the absorbance of a substance at a specific 
wavelength of a 1 g/100 ml solution in a 1cm cell. 
 
1.3.2 Deviation of Beer’s law 
 When the absorbance is plotted against concentration, a straight line passing 
through the origin should be obtained. But there is always a deviation from the linear 
relationship in the plot of absorbance versus concentration. The deviation in the 
Beer’s law may be due to anyone of the following reasons. 
The presence of foreign substance affects the light absorption and alters the 
extinction coefficient. 
 Due to dissociation or association of the molecule.  
 Example, benzyl alcohol in chloroform exists as a polymer. The 
monomer absorbs at lower wavelength and the polymer at higher 
wavelength. 
 Due to presence of foreign substance which absorbs at the same 
wavelength as the analyte. 
 If monochromatic light is not used. 
 Due to undesirable radiations falling on the detector. 
 If macromolecules are present. Example, proteins. 
 Presence of insoluble particles. Example, suspension. 
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1.3.3 Transitions in Organic Molecules  
  (Sharma, et al., 2007; Gurdeep R Chatwal, et al., 2009)                               
 The absorption in the ultraviolet region results in the transition of the valence 
electron form the ground level to the excited level. The three types of electrons 
involved in the transition are 
σ-electrons: These are involved in the formation of saturated bonds. The excitation 
energy for UV radiations is more than electrons in the atom. Hence these electrons do 
not absorb near UV radiation. 
π-electrons: These are involved in the formation of unsaturated bonds.           
Example: Dienes, trienes and aromatic compounds. It absorbs radiation in near UV 
region. 
n-electrons: These are the lone pair of electrons present in atoms such as oxygen, 
nitrogen etc., in a molecule. They can be excited by both UV and Visible radiations. 
 The various types of transitions are 
σ →σ* 
n→σ* 
π → π * 
n→π*
(http://www.pharmatutor.org/pharma-analysis/analytical-aspects-of-uv-
visible-spectroscopy/types-of-electrone-transition.html) 
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The energy required for the various types of transitions are  
σ→σ* > n→σ* > π → π * > n→ π * 
1.3.3.1 σ→σ* transitions 
 These transitions occur in saturated hydrocarbons with single bonds and no 
lone pair of electrons. The energy required for this type of transition is very high 
because of the strong sigma bond formed by the valence electrons. Thus, the 
transitions occur at very short wavelength. The saturated hydrocarbons such as 
methane, ethane, propane etc. absorbs at 126 -135 nm region of the UV region. Hence 
these compounds are used as solvents in UV spectroscopy. 
1.3.3.2 n → σ* transitions 
 Saturated compounds with lone pair of electrons show n→σ* transitions in 
addition to σ→σ* transitions. The energy required for the n→σ* transition is lesser 
than the energy required for σ→σ* transitions. The energy required for n→σ* 
transition, in alkyl halides, decreases with increase in the size of the halogen atom. 
Alcohols and amines forms hydrogen bonding with the solvent hence require higher 
energy for the transitions. 
1.3.3.3 π → π * transitions 
 These transitions occur in unsaturated compounds containing double or triple 
bonds and also in aromatic compounds. Lower energy is required for these transitions 
and hence a longer wavelength causes the excitation of the molecule. 
1.3.3.4 n→ π* transitions 
 These transitions occur in compound which contains oxygen, nitrogen, sulphur 
and halogens because of the presence of free lone pair of electrons. These transitions 
require least amount of energy and hence they occur in UV and Visible region. 
Saturated carbonyl compounds shows two types of transitions, low energy n→ π* 
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transitions occurring at longer wavelength and high energy n→ π* transitions 
occurring at lower wavelength. The shifts in the absorption of the carbonyl 
compounds are due to the polarity of the solvent. 
1.3.4 Transition Probability (Gurudeep R. Chatwal, et al., 2009) 
 It is not essential that, when a compound is exposed to UV light, transition of 
the electron should take place. The probability that an electronic transition should take 
place depends on the value of extinction coefficient. The transitions are classified as 
 Allowed transition 
 Forbidden transition 
1.3.4.1 Allowed transitions 
The transitions having εmax value greater than 104 are called allowed 
transitions. They generally arise due to the π → π * transitions. For example, 1, 3 – 
butadiene exhibits absorption maximum at 217 nm and has εmax value of 21000 
represents allowed transitions. 
1.3.4.2 Forbidden transitions 
These transitions have εmax value less than 104. They occur due to n→ π* 
transitions. Example, saturated carbonyl compound (R-C=O) shows absorption near 
290 nm and εmax value less than 100 represent forbidden transitions. 
1.3.5 Chromophore 
 These are groups or structure which is responsible to impart colour to the 
compound. The presence of chromophore is responsible for the absorption of UV 
radiation by any compound. The groups include nitro group, amine groups, double 
bonds, triple bonds, etc.  
There are two types of chromophore 
Groups containing π electrons and undergoes π → π * transitions. 
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Example: ethylenes, acetylenes 
Groups containing π electrons and n electrons. They undergo two types of transition 
like π → π * transitions and n→ π* transitions.  
Example: carbonyls, nitriles, azo compounds etc. 
1.3.6 Auxochrome 
Any groups which do not itself act as a chromophore but its presence brings a 
shift in the position of absorption maximum. Chromophores are unsaturated whereas 
the auxochromes are covalently saturated. The auxochromes are of two types 
Co-ordinately unsaturated, example –NH2, -S- groups containing lone pair of 
electrons. 
Co-ordinately saturated, example –NH3+ groups. 
1.3.7 Absorption and Intensity shifts 
1.3.7.1 Bathochromic shift or Red shift 
The shift in the absorption maximum of a compound, due to the presence of 
certain auxochromes, towards longer wavelength is called as the bathochromic shift. 
1.3.7.2 Hypsochromic shift or Blue shift 
The shift in the absorption maximum to shorter wavelength is called 
Hypsochromic shift. The shift is due to solvent effect or removal of conjugation in a 
molecule. 
1.3.7.3 Hyperchromic effect 
The increase in intensity of absorption by inclusion of an auxochrome to a 
system is hyperchromic shift. 
1.3.7.4 Hypochromic shift 
The decrease in the intensity of absorption is due to the distortion of the 
geometry of the molecule. 
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1.3.8 Solvent effect 
 The solvent used for the spectral analysis should not interfere in the 
absorbance of the analyte. It means that the solvent should not have any absorbance in 
the region under investigation. Based on the polarity of the solvent used the intensity 
of the absorption changes for a particular analyte. The α, β – unsaturated carbonyl 
compounds shows two different types of transitions 
n→ π* transition 
The increase in polarity moves the absorption maximum to a shorter wavelength. The 
ground state is more polar compared to the excited state. 
π → π * transitions 
The increase in polarity moves the absorption maximum to longer wavelength. Only 
lesser energy is required for this transition and hence shows red shift. 
1.3.9 Choice of solvent 
 There are two important requirements a solvent must satisfy to be used as a 
solvent in UV spectroscopy.  
There are 
It should be transparent throughout the region of UV under investigation 
It should not interact with the solute molecules and should be less polar. 
1.3.10 Instrumentation 
The components of a UV-Visible spectrophotometer are 
 Light source 
 Monochromators 
 Sample cell 
 Detectors 
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Light source 
 The various source of light used in the spectrophotometer are tungsten lamp, 
hydrogen discharge lamp, deuterium lamp, xenon arc lamp and mercury arc lamp. 
The most commonly used lamp is the deuterium discharge lamp. 
Monochromators 
 The monochromators are used to disperse the light for the required 
wavelength. The monochromators consists of three units entrance slit, dispersing 
element and exit slit. The dispersing unit may be filters, prisms or gratings. The fused 
silica prisms and quartz prisms are commonly used in UV spectrophotometers. 
Sample cell 
 The cell must be transparent throughout the wavelength region of study. The 
cells are made of fused glass or fused silica or quartz. The glass cells are not used 
since they absorb in the UV region. Quartz cells are commonly used. 
Detectors 
 The detectors employed are barrier layer cells, photo emissive tubes, 
photodiodes and photomultiplier tubes. Photodiodes are commonly used in the 
instrument.  
1.3.11 Spectrophotometers 
 There are two designs of spectrophotometer. They are single beam 
spectrophotometer and double beam spectrophotometer. 
Single beam system 
 Light given off from the source 
 Lens gathers the light and focuses on the monochromator 
 The light of specific wavelength comes out of the monochromator 
 Radiation passes through the sample in the sample cell and to the detector 
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 Detector measures the intensity of the light reaching it. 
 
 
 
UV-Visible Single beam spectrophotometer (chemistry.adelaide.edu.au) 
Double beam system 
 Radiation from source falls on the monochromator 
 The radiation of the required wavelength pass out of the exit slit reaches the 
rotating disc 
 Rotating disc splits the beam into two, one passes through the sample cell and 
the other passes through the reference cell 
 The light beam falls on the detector 
 Detector measures the intensity of the light. 
 
Double beam UV-Visible spectrophotometer (Chemguide.co.uk) 
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1.3.12 Quantitative analysis of single component 
(Beckett and Stenlake, et al., 2007) 
 The assay of an analyte is done by dissolving the analyte in a suitable solvent 
and measuring the absorbance of the solution at the required wavelength. The selected 
wavelength is the absorbance maximum of the analyte in that particular solvent. The 
concentration of the analyte can be determined by 
 Use of absorptivity value 
 Use of calibration graph 
 Single or double point standardization 
1.3.12.1 Absorptivity value method 
 This method is usually followed in official books such as Indian 
Pharmacopoeia, British Pharmacopoeia etc. The advantage of the method is, the 
preparation of standard solutions of reference substance is not required for the 
calculation of the concentration of the analyte. 
1.3.12.2 Calibration graph method 
 In this method, a series of linear concentration solutions of the reference 
solutions are prepared and the value of absorbance is plotted against the concentration 
of the reference solution. From the graph the absorbance of the sample solution is 
plotted and the concentration is found. 
1.3.12.3 Single point or double point standardization 
 In single point standardization, the standard and the sample solutions are 
prepared under same identical condition. Also, the standard and the sample 
concentration are almost equal. Then after the measurement of absorbance the 
following formula is applied to find the unknown sample concentration 
ܥ௧௘௦௧ = ܣ௧௘௦௧ܣ௦௧ௗ × ܥ௦௧ௗ 
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 Double point standardization is used when there is a linear but non 
proportional relationship between concentration and absorbance. The concentration of 
one of the standard is higher and the concentration of other is lower than that of the 
standard. 
ܥ௧௘௦௧ = (ܣ௧௘௦௧ − ܣ௦௧ௗଵ)(ܥ௦௧ௗଵ − ܥ௦௧ௗଶ) + ܥ௦௧ௗଵ(ܣ௦௧ௗଵ − ܣ௦௧ௗଶ)ܣ௦௧ௗଵ − ܣ௦௧ௗଶ  
 
1.3.13 Assay of substance in multi component samples 
 The multi component analysis is done when the sample contains more than 
one analyte to be quantified in the sample. In such methods one of the analyte may be 
taken as interferent and the absorbance of the interferent reduced to find the true 
absorbance of the analyte. Similarly the absorbance of the other analyte is found by 
taking the first analyte as the interferent.  
The determination of the multi-component samples can be done by using the 
following methods:  
 Assay of a single-component sample 
 Assay using absorbance corrected for interference 
 Assay after solvent extraction of the sample 
 Simultaneous equations method 
 Absorbance ratio method (Q-Analysis) 
 Geometric correction method 
 Orthogonal polynomial method 
 Difference spectrophotometry 
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 Derivative spectrophotometry 
 Area under curve method 
 Chemical derivatization 
 
Method  carried  out 
Derivative spectroscopy 
Derivative Spectroscopy 
 Derivative spectrophotometry involves the conversion of a normal spectrum to 
its first, second or higher derivative spectrum. The transformations that occur in the 
derivative spectra are understood by reference to a Gaussian band which represents an 
ideal absorption band. In the context of derivative spectrophotometry, the normal 
absorption spectrum is referred to as the fundamental, zero order or D° spectrum. 
The first derivative (D1) spectrum is a plot of the ratio of change of absorbance 
with wavelength against wavelength, i.e. a plot of the slope of the fundamental 
spectrum against wavelength or a plot of dA/dλ Vs λ. At λ2 and λ4, the maximum 
positive and maximum negative slope respectively in the D°. Spectrums correspond 
with maximum and a minimum respectively in the D1 spectrum. The λmax at λ3 is a 
wavelength of zero slopes and gives dA/d λ 0, i.e. a cross-over point, in the D1 
spectrum.  
The second derivative (D2) spectrum is a plot of the curvature of the D° 
spectrum against wavelength or a plot of d2A/dλ2 Vs λ. The maximum negative 
curvature at λ3 in the D° spectrum gives a minimum in the D2 spectrum, and at λ1 and 
λ5 the maximum positive curvature in the D° spectrum gives two small maxima called 
‘satellite’ bands in the D2 spectrum. At λ2 and λ4 the 
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The zeroth (a), first (b) and second (c) derivative spectra of a Gaussian band. 
Wavelengths of maximum slope and zero curvature in the D° spectrum correspond 
with cross-over points in the D2 spectrum. 
In summary, the first derivative spectrum of an absorption band is 
characterized by a maximum, a minimum, and a cross-over point at the λmax of the 
absorption band. The-second derivative spectrum is characterized by two satellite 
maxima and an inverted band of which the minimum corresponds to the λmax of the 
fundamental band.  
These spectral transformations confer two principal advantages on derivative 
spectrophotometry. Firstly, an even order spectrum is of narrower spectral bandwidth 
than its fundamental spectrum. Secondly, derivative spectrophotometry discriminates 
in favour of substances of narrow spectral bandwidth against broad bandwidth 
substances. This is because ‘the derivative amplitude (D), i.e. the distance from a 
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maximum to a minimum, is inversely proportional to the fundamental spectral 
bandwidth (14’) raised to the power (n) of the derivative order. Thus,               
                           D α ( 1/W )n 
Consequently, substances of narrow spectral bandwidth display larger derivative 
amplitudes than those of broad bandwidth substance 
 
 
 
 
 
 
 
(a) The individual spectra of two components X and Y in admixture and their 
combined spectrum. (b) The second derivative spectrum of the mixture showing 
improved resolution of the individual bands. 
The enhanced resolution and bandwidth discrimination increases with 
increasing derivative order. However, it is also found that the concomitant increase in 
electronic noise. Inherent in the generation of the higher order spectra, the consequent 
reduction of the signal-to-noise ratio, place serious practical limitations on the higher 
order spectra. 
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1.4 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
   (Sharma, et al., 2000) 
  The  high  performance  liquid  chromatography  is  thus  a  method  of  
separation in  which  the  stationary  phase  is  contained  in  a  column  one  end  
which  is attached  to  a  source  of  pressurized  liquid  eluent  (mobile phase ). 
The  choice  of  mobile  phase  is  very  important  in  HPLC  and  the  eluting 
power  of  the  mobile  phase   is  determined  by  its  overall  polarity  of the 
stationary  phase  and  the  nature  of sample components  for normal phase  
separation   eluting  power   increases  with   increasing  polarity of the solvent ,but 
for reversed  phase separations,  eluting power  decreases with increasing solvent 
polarity. 
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1.4.1. MODES OF SEPARATION         (Lloyd, et al., 1997) 
i. Reversed-phase chromatography 
 Reversed-phase chromatography (RPC) is the first choice for most regular 
samples.  RPC s typically more convenient and rugged than other forms of liquid 
chromatography and is more likely to result in a satisfactory final separation.  High-
performance RPC columns are efficient, stable, and reproducible.  Detection often is 
easier in RPC because of the solvents used. Finally,  most  workers  have  more  
experience  with  RPC  than  with  other  HPLC methods. 
 Although  many  organic  compounds  have  limited  solubility  in  the  mobile 
phase,  this  is  not  a  practical  limitation  because  only  small  amounts  (nanograms 
or micrograms)  of  sample are usually injected. In those cases where sample 
solubility in RPC mobile phases is exceptionally poor, normal-phase chromatography 
is a preferred alternative.  Similarly,  samples  that  are  unstable  in  aqueous  media  
can  also  be  separated  by  normal  phase  chromatography  using non-aqueous  
solvents. 
ii. Normal-phase chromatography 
 In normal-phase chromatography (NPC) the stationary phase is more polar 
than the mobile phase, the opposite of RPC. Usually, the mobile phase is a mixture of 
organic solvents without added water and the column packing is either an inorganic 
adsorbent (silica or occasionally alumina) or a polar bonded phase (cyano, diol, or 
amino) on a silica support. Regardless of the mobile or stationary phase used, sample 
retention in NPC increases as the polarity of the mobile phase decreases (the opposite 
of RPC). 
 NPC has been used for separating both neutral and ionic compounds, but 
neutral samples predominate. NPC for ionic samples can involve the use of water in 
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the mobile phase, and the retention process is then somewhat complex. When ionic 
samples are separated by NPC, it is usually advisable to add triethylamine to the 
mobile phase for basic compounds and acetic or formic acid for acidic compounds. 
Neutral samples are often separated equally well by either RPC or NPC, the main 
difference being a reversal of elution order for the two HPLC methods. In NPC, less 
polar compounds elute first, while more polar compounds leave the column last: this 
behavior can be contrasted with the opposite RPC behavior. 
iii. Ion-pair chromatography 
 Ion-pair and reversed-phase HPLC share several features. The column and 
mobile phase used for these separations are generally similar, differing mainly in the 
addition of an ion-pair reagent to the mobile phase for ion-pair chromatography (IPC). 
For most applications that involve ionic samples, RPC separation should be explored 
first, before considering IPC. IPC separations are more complicated to develop and 
are subject to additional experimental separation due to poor band spacing, IPC 
provides an important additional selectivity option. Thus IPC is a logical follow-up 
for RPC separations that need improvement. 
iv. Ion-exchange chromatography 
 Ion exchange chromatography (IEC) was an important HPLC method. Its 
application for the separation of most sample types gradually diminished compared to 
other HPLC methods. Today it is used infrequently, except for certain “special” 
samples. These include mixtures of biological origin, inorganic salts, and some 
organometallics.  
 Because of the similarity of ion-exchange and ion-pair HPLC retention, many 
separations that are possible using IEC can also be achieved using IPC. For the 
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separation of typical small-molecule samples, IPC may have certain advantages like 
higher column efficiencies, easier control over selectivity and resolution, and more 
stable and reproducible columns. 
1.4.2. Elution techniques     (Sharma, et al., 2000) 
 Two types of elution techniques generally used. They are, 
i) Isocratic elution 
One particle solvent or mixture is pumped through the whole analysis. 
ii) Gradient elution 
            For some determinations the solvent composition may be altered 
gradually gradient elution system can be classified as low pressure and high pressure 
system. In low pressure gradient elution system the eluent components are miner 
proportion varying with time at low pressure and the mixture is pumped in order to be 
delivered at high pressure to the column. In high pressure gradient elution system 
components or mixtures of fixed composition are each pumped by separate pump and 
then mixed at high pressure in a ratio varying with time. 
1.4.3. REVERSE-PHASE HIGH PERFORMANCE LIQUID 
CHROMATOGRAPHY  (Mendham, et al., 2002) 
High performance systems have meant that liquid chromatography has over 
taken gas chromatography as HPLC now provide the following features, 
1. High Resolving Power 
2. Speedy separation 
3. Continuous monitoring of the column effluent 
4. Accurate quantitative measurement 
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5. Repetitive and reproducible analysis using some columns 
1.4.3.1. Mobile Phase 
 
A successful chromatographic separation depends upon differences in the 
interaction of the solutes with the mobile phase and the stationary phase. In liquid 
chromatography, the choice and variation of the mobile phase is of critical importance 
in achieving optimum efficiency.  HPLC grade solvents tend to be costly.  To ensure 
consistent performance, the solvent should not contain any trace amounts of other 
materials, including water for organic solvents. 
1.4.3.2. Pumping Systems    (Douglas, et al., 2004; Willard, et al., 1986) 
The requirements for liquid chromatographic pumps include 
 Ability to generate pressures of up to 6000 psi (Ibs/in2) 
 Pulse free output 
 Flow rate ranging from 0.1 to 10 ml/min 
 Flow reproducibility of 0.5% relative or better 
 Resistance of corrosion by a variety of solvents 
Types of pumps 
 Reciprocating Piston Pumps 
 Syringe Type Pump 
 Constant Pressure Pump 
1.4.3.3. Columns for HPLC (Willard, et al., 1986) 
The columns most commonly used are made from precision bore polished 
stainless steel tubing; typical dimensions are 10-30 cm long and 4 (or) 5 mm internal 
diameter.  The stationary phase (or) packing is retained at each end by thin stainless 
steel frits with a mesh of 2 µm or less. The packing used in modern HPLC consist of 
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small, rigid particles having a narrow particles size distribution. The types of column 
used in HPLC are 
 Standard columns 
 Radial compression columns 
 Narrow Bore columns 
 Short, fast columns 
 Guard columns and In-line filters 
1.4.3.4. Temperature Control 
Separation columns should be housed within a stable system with temperature 
variations of less than 0.1°C, the temperature changes must be avoided. Circulating 
air bath or electrically heated chambers are used to control the column temperature. 
The solvent is preheated separately before entering the separation column. 
1.4.3.5. Detectors (Ashutoshkar, et al., 2005) 
The main function of the detector in HPLC is to monitor the mobile phase 
coming out the column, which in turn emits electrical signals that are directly 
proportional to the characteristics either of the solute or the mobile phase. 
Basic detector requirements 
An ideal LC detector should have the following properties: 
1. Low drift and noise level (particularly crucial in trace analysis). 
2. High sensitivity 
3. Fast response 
4. Wide linear dynamic range (this simplifies quantitation) 
5. Low dead volume (minimal peak broadening) 
 
 
25 
 
Types of detectors 
Detector Types of molecules General 
Refractive Index Detector Carbohydrates, Polymers Molecules that do not have 
a UV chromophore, cannot 
UV/Vis, Pho diode array 
detector 
Organic molecules, bio 
molecules expect   
carbohydrates 
Any molecule that absorbs, 
light between 170 and 700 
nm, PDAs are typically 
used either when the 
molecules in the mixture 
absorb at different 
wavelengths or when the 
wavelength of maximum 
absorption is unknown. 
PDAs can be used for 
determining peak 
Fluorescence Aromatic compounds 
(PAHs) AccQTag, 
Generally used for 
applications that require 
extremely high sensitivity 
ELSD Evaporating light 
scattering detector 
Carbohydrates, Polymers Molecules that do not have 
a UV chromospheres, can 
be used with gradients, 
generally more sensitive 
that a RI detector 
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Mass spectrometer Organic molecules, bio 
molecules 
Can be used to detect and 
determine the mass on any 
molecule that can be 
ionized and is within the 
mass range of the specific 
MS 
MS/MS Organic molecules, bio 
molecules 
Detect and determine the 
mass of any molecule that 
can be ionized and is 
within the mass range of 
the specific Ms and 
detailed structural studies 
to be performed 
ECD Electrochemical 
detector 
Carbohydrates, man other 
organic molecules whose 
redox potential is different 
than the mobile  
Can provide extra 
sensitivity and selectivity 
for molecules that are not 
readily detected by device 
Conductivity Cations and Anions Used almost exclusivel for 
ion chromatography 
 
1.4.4. THEORY OF OPERATION 
   Column efficiency (Lloyd, et al., 1997; Willard, et al., 1986) 
          Column efficiency refers to the performance of the stationary phase to 
accomplish particular separations. Column efficiency is a function of different 
separation variables. This entails how well the column is packed and its kinetic 
performance. The efficiency of a column can be measured by several methods which 
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may or may not be affected by chromatographic anomalies, such as "tailing" or 
appearance of a "front". This is important because many chromatographic peaks do 
not appear in the preferred shape of normal Gaussian distribution. For this reason, 
efficiency can be an enigmatic value since manufacturers may use different methods 
in determining the efficiency of their columns. 
Calculation of column efficiency value           
 Inflection method 
 Half-peak height method 
 Tangent method 
 Sigma Method 
 Height/Area method 
 Moment method   
1.4.5. QUANTITATIVE ANALYSIS 
          Quantification involves the measurement of peak height or peak area. To 
determine the concentration of a compound, the peak area or height is plotted vs the 
concentration of the substance.  For well resolved peaks, both peak height and area 
are proportional to the concentration.   Four different calibration methods used in 
quantitative analysis are, 
a. Normalized peak area 
b. External standard addition method 
c. Internal standard addition method  
d. Standard addition method 
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a. Normalized peak area  
After completion of a run and the integration of all significant peaks in the 
chromatogram, the total peak area can be calculated. This technique is widely used to 
estimate the relative amount of small impurities or degradation compound in a 
purified material. The area present of any individual peak is referred to as the 
normalized peak area. The technique of normalized peak area is actually not a 
calibration method, since there is no comparison to a known amount for any peak in 
the chromatogram.  
b. External standard calibration 
The most general method for determining the concentration of an unknown 
sample is to construct a calibration plot using external standards. Standards are 
prepared at known concentrations. A fixed volume of each standard solution is 
Injected and analyzed, and the peak responses are plotted Vs concentration. The 
standard solutions are referred to as external standards, since they are prepared and 
analyzed in separate chromatograms from those of the unknown samples. Unknown 
samples are then prepared, injected and analyzed in exactly the same manner. 
c. Internal standard calibration 
 Another technique for calibration involves the addition of an internal standard 
to the calibration solutions and samples. The internal standard is a different compound 
form the analyte, but one that is well resolved in the separation. The internal standard 
can compensate for changes in sample size or concentration to instrumental 
variations. With the internal standard method, a calibration plot is produced by 
preparing and analyzing calibration solutions containing different concentration of the 
compound of interest with a fixed concentration of the internal added. 
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The Internal standard comply the following requirements: 
 Well resolved from the compound of interest and other peaks. 
 Similar retention (k) to the analyte. 
 Should not be in the original sample 
 Should mimic the analyte in any sample preparation steps. 
 Does not have to be chemically similar to analyte. 
 Commercially available in high purity. 
 Stable and unreactive with sample or mobile phase. 
 Should have similar detector response to the analyte for the concentration used 
 It must be separated from all compounds of interest in the separation. 
d. Method of standard addition 
 A calibration standard ideally should be prepared in a blank matrix of drug 
formulation components without the drug substance or an animal without added 
compound usually can be used for standard calibration solutions. The method of 
standard addition is most often used in trace analysis. In this approach, different 
weights of analyte(s) are added to the sample matrix, which initially contains an 
unknown concentration of the analyte. Extrapolation of a plot of response found for 
the standard addition calibration concentration to zero concentration defines the 
original concentration in the unspiked sample. 
 
 
 
 
30 
 
1.5. ICH Guidelines for Analytical Method Validation Parameters 
(Code Q2A; Q2B, ICH Guidelines 1994 and 1995) 
The analytical methods are validated as per the ICH and USFDA guidelines. 
The objective of validation of analytical method is to prove that the method is suitable 
for the specific purpose. Analytical procedure refers to the way of doing an analysis. 
It describes completely all the steps involved in performing the analysis. The types of 
analytical procedure to be validated are 
 Identification tests 
 Quantitative test for impurities 
 Limit test for impurities 
 Quantitative analysis of the active drug 
The various validation parameters specified in the ICH and USFDA guidelines are 
 Accuracy 
 Precision 
 Specificity 
 Limit of detection 
 Limit of quantification 
 Linearity 
 Range 
 Robustness 
 Ruggedness 
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Accuracy 
The word accuracy refers to term trueness. It expresses the closeness between 
the true value or the reference value and the value found in the analysis. True value is 
the accepted value of the reference value. The accuracy is determined by the recovery 
studies. 
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Precision 
Precision expresses the degree of scatter between a series of measurement 
made in multiple sampling from the same homogenous sample. It may be considered 
under three levels 
 Repeatability 
 Intermediate precision 
 Reproducibility 
The precision is expressed as Variance, standard deviation and coefficient of 
variation for a series of measurements. 
The repeatability is confirmed by a minimum of 6 estimations at 100% of test 
concentrations. The standard deviations should be less than 2. 
The intermediate precision is confirmed by inter day and intraday analysis, 
different instruments and different analyst. 
Specificity 
Specificity refers to the ability of the method to assess the analyte in the 
presence of other components like impurities, matrix or degradants, etc. The 
implications of specificity are 
Identification: to ensure identity 
Purity tests: to determine the content of impurity 
Assay: content of the analyte in the sample 
Limit of Detection 
It is the lowest amount of an analyte that can be detected by the analytical 
procedure but cannot be quantified exactly. 
The LOD is performed based on the following parameters 
 Based on visual examination 
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 Based on signal to noise ratio 
 Based on the standard deviation and slope value. 
The visual examination is done by analysing the sample with known quantity 
of standard and by establishing the minimum level at which the analyte can be 
detected. 
A signal to noise ratio of 3 o 2.1 is considered as acceptable value for 
calculating the detection limit. Based on slope and standard deviation values, 
Detection limit can be calculated by using the formula, 
                   3.3σ 
LOD= -----------        
      S 
 
σ = the standard deviation of the response 
S = the slope of the calibration curve (of the analyte) 
Limit of quantification 
The lowest amount of the analyte which can be quantified by an analytical 
method with precision and accuracy is the limit of quantification. 
Three approaches are made for determining the quantification limit. They are 
similar to that of determining the detection limit. 
 Based on visual examination 
 Based on signal to noise ratio 
 Based on slope and standard deviation value 
        10σ 
LOQ = ----------- 
         S 
Where 
σ = the standard deviation of the response. 
S = the slope of the calibration curve (of the analyte). 
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Linearity 
Linearity is the ability of an analytical method to obtain results which are 
directly proportional to the analyte concentration within a given range. The linearity is 
evaluated as a plot of signals as a function of analyte concentration. The statistical 
parameters such as the slope, intercept, regression equation and correlation coefficient 
are calculated. For establishing of linearity, a minimum of 5 concentrations is 
required. 
Range 
It is the interval between the lower and upper limit of concentration in a 
sample for which the analytical method has suitable precision, accuracy and linearity. 
The minimum range considered for the assay of drug or finished product is form 80 to 
120 percent of the test concentration. 
Robustness 
It is the ability of an analytical method to remain unaltered by small but 
deliberate variations in various parameters of the method and indicate its reliability. 
The typical variation includes stability of analytical solutions and extraction time. In 
case of HPLC, the change in the ratio of mobile phase, flow rate, variation of pH of 
the solution are done for determining the robustness of the method. 
Ruggedness 
 The united states of pharmacopoeia (USP) define ruggedness as the degree of 
reproducibility of test results obtained by the analysis of the same sample under a        
variety of normal test condition such as different labs, different analysis, different lots 
of reagents etc. Ruggedness is a measure of reproducibility of test results under                  
normal expected operational conditions from laboratory to laboratory and from                   
analyst to analyst. 
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Acceptance criteria of validation for HPLC 
S.No. Characteristics Acceptance Criteria 
1 Accuracy Recovery 98-102% with 80,100,120% spiked sample. 
2 Precision RSD < 2% 
2a Repeatability RSD < 2% 
2b Intermediate precision RSD < 2% 
3 Specificity/ selectivity No interference 
4 Detection Limit S/N > 2 or 3 
5 Quantitation  Limit S/N > 10 
6 Linearity r = 0.999 
7 Range 80-120% 
8 Stability >24 hr or > 2hr 
 
1.6. SYSTEM SUITABILITY 
System suitability is the checking of a system to ensure system performance 
before or during the analysis of unknowns. Before performing any validation 
experiment, you should establish that the HPLC and the procedure are capable of 
providing data of acceptable quality. These tests are to verify that the resolution and 
repeatability of the system are adequate for the analysis to be performed. It is based 
on the concept that equipment, electronics, analytical operations and sample constitute 
an integral system that can be evaluated as a whole. 
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System suitability parameters and recommendations 
S.No. Parameters Recommendations 
1 Theoritical plates (N) >2000 
2 Tailing factor (T) ≤ 2 
3 Assymetric factor ≤ 2 
3 Resolution (Rs) 
> 2 between peak of interest and the closest 
eluting potential interference 
4 Repeatability RSD ≤ 1% for N ≥5 is desirable 
5 Capacity factor (k1) > 2.0 
6 Relative retention Not essential as long as the resolution is stated 
  
1.6.1. SYSTEM SUITABILITY PARAMETERS   
(Lloyd, et al., 1997; Beckett and Stenlake, et al., 2007) 
System suitability testing is an integral part of many analytical procedures. 
The tests are based on the concept that the equipment, electronics, analytical 
operations, and samples to be analyzed constitute an integral system that can be 
evaluated as such. System suitability test parameters to be established for a particular 
procedure depend on the type of procedure being validated.  
The parameters that are affected by the changes in chromatographic conditions 
are, 
 Column capacity factor (KA) 
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 Resolution (Rs) 
 Selectivity () 
 Column efficiency (N)  
 Peak asymmetry factor (As) 
 Tailing factor (T) 
1.6.1.1. Column capacity factor (KA) 
The retention of a drug with a given packing material and eluent can be 
expressed as retention time or retention volume, but both of these are dependent on 
flow rate, column length and column diameter. The retention is best described as a 
column capacity ratio (K), which is independent of these factors. The column capacity 
ratio of a compound (A) is defined as  
0
0A
0
0A
A t
tt
V
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K



  
Where, 
VA = Elution volume of A 
V0 = Elution volume of a non retained compound (void volume) 
At constant flow rate, retention times (tA and to) can be used instead of 
retention volumes. Retention data is sometimes expressed, relative to a known 
internal standard (B). The ratio of retention times (tA/tB) can be used, but the ratio of 
adjusted retention times  







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 is better when data need to be transferred 
between different chromatographs. 
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The values of k’ of individual bands increase or decrease with changes in 
solvent strength. In reversed phase HPLC, solvent strength increases with the increase 
in the volume of organic phase in the water / organic mobile phase. Typically an 
increase in percentage of the organic phase by 10 % by volume will decrease k’ of the 
bands by a factor of 2-3.  
1.6.1.2 Resolution (Rs) 
The resolution, Rs of two neighboring peaks is defined by the ratio of the 
distance between the two peak maxima. It is the difference between the retention 
times of two solutes divided by their average peak width. For baseline separation, the 
ideal value of Rs is 2.0. It is calculated by using the formula, 
)WW(5.0
RtRt
R
21
12
f 

  
Where,  
Rt1 and Rt2 are the retention times of components 1 and 2  
W1 and W2 are peak widths of components 1 and 2. 
1.6.1.3. Selectivity () 
The selectivity (or separation factor), , is a measure of relative retention of 
two components in a mixture. The ideal value of selectivity is 2. It can be calculated 
by using the formula,   
01
02
VV
VV


  
Where, V0 is the void volume of the column and V2 and V1 are the retention    
volumes of the second and the first peak, respectively. 
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1.6.1.4. Column efficiency 
Efficiency, N, of a column is measured by the number of theoretical plates per 
meter. It is a measure of band spreading of a peak. Smaller the band spread, higher is 
the number of theoretical plates, indicating good column and system performance. 
Columns with N ranging from 5,000 to 1,00,000 plates/meter are ideal for a good 
system. Efficiency is calculated by using the formula, 
2
2
16
W
RtN   
Where, Rt is the retention time and W is the peak width. 
1.6.1.5. Peak asymmetry factor (As) 
Peak asymmetry factor, As can be used as a criterion of column performance. 
The peak half width b of a peak at 10 % of the peak height, divided by the 
corresponding front half width a gives the asymmetry factor. 
a
bAS   
1.6.1.6. Tailing factor (T) 
The tailing factor T, a measure of peak symmetry, is unity for perfectly 
symmetrical peaks and its value increases as tailing becomes more pronounced. 
In some cases, values less than unity may be observed. As peak asymmetry 
increases, integration, and hence precision becomes less reliable. 
T = W଴.଴ଽ 2f  
 
Where, 
40 
 
            W0.05 = width of peak at 5% height 
f = Distance from the peak maximum to the leading edge of the peak, the 
distance being measured at a point 5% of the peak height from the baseline. 
Limit:  ≤  2 is preferable.  
1.6.1.7. Height Equivalent to a Theoretical Plate (HETP) 
A theoretical plate can be of any height, which decides the efficiency of 
separation. If HETP is less the column is more efficient. If HETP is more, the column 
is less efficient. The height equivalent to a theoretical plate (HETP) is given by 
HETP =  Length of the columnNo. of the theoretical plates 
1.7 BASIC STATISTICAL PARAMETERS (Takeru Higuchi, et al., 2001; Gupta, 
et al., 1994) 
In analytical chemistry, statistical methods are unavoidable .whether it is a 
calibration Curve or the result of single or multi analysis interpretation can only be 
ascertained if the margin of error is known, when the measurement is repeated, a 
statistical analysis is compulsory. Total quality control on a statistical basis give 
promise of making pharmaceutical manufacturing more efficient. 
1.7.1 Linear Regression 
Once a linear relationship has been shown to have a high probability by the 
value of the correlation coefficient ‘r’, then the best straight line through the data 
points has to be estimated. This can often be done by visual inspection of the 
calibration graph, but in many cases it is far more sensible to evaluate the best straight 
line by linear regression (the method of least squares). The equation of straight line is 
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                                                      y = mx + c 
Where, y the dependent variable is plotted as result of changing x, the 
independent variable. To obtain the regression line ‘y on x’ the slope ‘m’ of the line 
and the intercept ‘c’ on the y axis are given by the following equation. 
m = N Σxy – (Σx) (Σy)N Σxଶ– Σ(x)ଶ  
c = (Σy)(Σxଶ) – (Σx) (Σy)N Σxଶ– Σ(x)ଶ  
1.7.2. Correlation Coefficient 
To establish whether there is a linear relationship between two variables x1 
and y1, use Pearson’s correlation coefficient r. 
r =  nΣxଵyଵ − Σxଵyଵ{[nΣxଵଶ − (Σxଵ)ଶ][nΣyଵଶ − (Σyଵ)ଶ]}ଵ/ଶ 
Where, n is the number of data points. 
The value of r must lie between +1 and -1, the nearer it is to +1, the greater the 
probability that a definite linear relationship exists between the variables x and y, 
values close to +1 indicate positive correlation and values close to -1 indicate negative 
correlation values of ‘r’ that tend towards zero indicate that x and y are not linearly 
related (they made be related in a non-linear fashion). 
1.7.3. Standard Deviation              
 It is commonly used in statistics as a measure of precision and is more 
meaningful than the average deviation. It may be thought of as a root-mean-square 
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deviation of values from their average and is expressed mathematically as  
 
 
Where SD is Standard deviation 
n = Large (50 or more) then of course it is immaterial whether the term in the 
denomination is n -1 or n 
Σ= Summation 
x = Mean or arithmetic average 
x - ⃑ݔ = Deviation of a value from the mean 
n = Number of observations 
1.7.4. Percentage Relative Standard Deviation (%RSD) 
            It is also known as coefficient of variation. It is defined as the standard 
deviation (S.D) expressed as the percentage of mean.  
C 100
x
S.DRSD  %or  V   
Where, S D = Standard deviation 
⃑ݔ = Mean or arithmetic average 
The variance is defined as S2 and is more important in statistics than S itself. 
However, the latter is much more commonly used with chemical data. 
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1.7.5. Standard Error of Mean (S.E.) 
Standard error of mean can be defined as the value obtained by division of 
standard deviation by square root of number of observations. It is mathematically 
expressed as, 
n
S.D.S.E.  
Where, S D = Standard deviation  
n = number of observations 
 
 
 
 
 
LITERATURE REVIEW 
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2. LITERATURE REVIEW 
2.1 DRUG PROFILE 
 (The Merck Index, 2006; Indian Pharmacopeia, 2007; The British 
Pharmacopeia, 2009) 
2.1.1AMLODIPINE BESYLATE  
Molecular Structure 
N
H
O
NH2
O
O CH3O
O
CH3
CH3
Cl
,
SO3H
 
Chemical Name 
3-ethyl 5-methyl2-[(2-aminoethoxy) methyl]-4-(2-chlorophenyl)-6-methyl-1, 
4-dihydropyridine-3,5-dicarboxylate benzene sulphonate. 
Molecular Formula 
 C26H31ClN2O8S 
Molecular Weight 
567.1g/mol 
Description 
 It is a white or almost white powder. 
Solubility 
 Slightly soluble in water, freely soluble in methanol, sparingly soluble in 
ethanol, slightly soluble in 2-propanol. 
Storage 
 Store protected from light. 
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pka Value 
 8.6 
Storage 
 In an airtight container and protected from light. 
Purity 
 98.0 to 102.0 
IDENTIFICATION 
Melting Point. 
 
 
 
*Average of six determinations 
1) IR Spectrum 
IR spectrum of Amlodipine besylate is compared with the standard 
Amlodipine besylate IR Spectrum and principal peaks at a wave numbers (KBr disc) 
were identified. It is shown in Figure 1. 
PHARMACOLOGY AND TOXICOLOGY 
Category  
 Amlodipine besylate is a Antihypertensive Agent, Vasodilator Agent, Calcium 
Channel blockers and Antianginal. 
 
 
Standard Value Observed Value* 
199-201°C 200.3°C 
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Indications and dosage    
  Adultzz : Initially 5 mg once daily, increased over 7-14 days. 
  Elderly : Initially 2.5 mg/day, increased as required 
  Max Dose : Adult 10 mg/day 
Mechanism of action   
  Amlodipine inhibits the movement of calcium ions (Ca2+) across the cell 
membrane into vascular smooth muscles and myoctes. Action is greater in the arterial 
resistant vessels causing peripheral vasodilatation and reduction in after load. Action 
on the myocardium is considerably less. Clinically, blood pressure is reduced without 
significant increase in heart rate. In angina patients reduction of after load reduces 
myocardial oxygen requirement. Severity and frequency of angina attacks are reduced 
while exercise tolerance is increased. 
Pharmacokinetics (Martindale, 2005) 
Absorption 
Rapidly and completely absorbed with systemic bio-availability of 60 to 65 % 
in oral dosage form. 
Distribution 
 97.5 % bind to plasma protein albumin. 
Metabolism 
 Extensively metabolized in the liver. 
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Elimination 
 95 % was eliminated through urine together with less than 10% of a dose of 
unchanged form. 
Protein binding  
71-79% 
Half-Life 
 30 hours  
Adverse Effect 
Peripheral edema, headache, dizziness, lassitude, fatigue, mild hypokalaemia, 
gingival enlargement, insomnia, tachycardia and hyperglycemia. 
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2.1.2. INDAPAMIDE 
Molecular Structure 
N
CH3
NH
O S
NH2
O O
Cl
 
Chemical Name 
4-chloro-N-[(2RS)-2-methyl-2, 3-dihydro-1H-indol-1-yl]-3-
sulphamoylbenzamide. 
Molecular Formula 
 C16H16ClN3O3S 
Molecular Weight 
 365.84 g/mol 
Description 
 White or almost white powder. 
Solubility 
 Practically insoluble in water, soluble in alcohol and slightly soluble in ether. 
Storage 
 Store protected from light. 
pka Value 
 8.8  
Purity 
 98.0 to 102.0 
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IDENTIFICATION 
1) Melting point 
 
 
 
*Average of six determinations 
2) IR Spectrum  
 IR Spectrum of Indapamide is compared with the standard Indapamide IR 
Spectrum and Principal peak at a wave numbers (KBr disc) were identified. It is 
shown in Figure 2. 
PHARMACOLOGY AND TOXICOLOGY 
Category 
 Antihypertensive Agents and used as Diuretics. 
Indications and dosage 
Exerts antihypertensive effects at doses lower than those for diuretic action 
possible relaxation of vascular smooth muscle my inhibition of net Ca2+ inflow. 
Adult  : Initially 5 mg once daily, increased over 7-14 days. 
  Elderly : Initially 2.5 mg/day, increased as required 
Max Dose : Adult 10 mg/day 
 
 
Standard Value Observed Value* 
160-162°C 161.0°C 
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Mechanism of Action 
 Indapamide blocks the slow component of delayed rectifier potassium current 
(IKs) without altering the rapid component (IKr) or the inward rectifier current. 
Specifically it blocks or antagonizes the action the proteins KCNQ1 and KCNE1. 
Indapamide is also thought to stimulate the synthesis of the vasodilator hypertensive 
prostaglandin PGE2. 
Pharmacokinetics (Martindale, 2005) 
Absorption 
Rapidly and completely absorbed from gastrointestinal tract. 
Distribution 
 Strongly bound to red blood cells. 
Metabolism  
Extensively metabolized by hepatic. 
Elimination 
 About 60 to 70% of the dose has been reported to be excreted in the urine; 
only about 5 to 7% is excreted unchanged. About 16 to 23% of dose is excreted in the 
faeces. 
Protein binding  
71-79% 
Half-Life 
 14 hours (bi phasic) 
 Adverse Effect 
Headache, dizziness, electrolyte imbalance (potassium or salt depletion due to 
too much fluid loss), nausea, weakness. 
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2.2        REPORTED METHODS 
2.2.1  REPORTED METHODS FOR AMLODIPINE BESYLATE  
1. Abdullah Al Masud et al. (2011) 
                      “Validated RP-HPLC method for simultaneous estimation of 
Amlodipine Besylate and Atorvastatin Calcium”. 
Stationary phase   :  C18 column (250×4.6 mm, 5 μ 
Mobile Phase        :  0.02 M phosphate buffer solution and acetonitrile as 
               (50:50) v/v)                                 
Flow rate              : 1.0 mL /min 
Detection            : PDA detector  
Wavelength         : 238 nm. 
Retention time    : AML - 3.5 min ATR - 16.4 min 
2. Vijayavichare et al. (2011) 
“Spectrophotometric simultaneous determination of amlodipine 
besylate and hydrochlorothiazide in combined tablet dosage form by absorption ratio 
and first order derivative spectroscopy methods”. 
Solvent   : Methanol for Method A and method B 
Method A   :  Absorption Ratio 
Wavelength   :  Amlodipine besylate -271, Hydrochlorothiazide-238.5 
Method B   :  First order Derivative Spectroscopy 
Wavelength   :  Amlodipine besylate -271, Hydrochlorothiazide-238.5 
Linear Range  :  AML: 2.5‐25, 2.5‐50 µg/ml. HYD: 1‐10, 1‐20µg/ml. 
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3.  Devi Ramesh et al. (2010)  
“New spectrophotometric methods for simultaneous determination of 
Amlodipine besylate and Atorvastatin calcium in tablet dosage forms”. 
Method A  :   Simultaneous equation 
Wavelength  :   Atorvastatin calcium at 331 nm and Indapamide 246 nm 
Solvent :  Methanol 
Range      :  0.5‐30 μg/mL 
Method B : Q‐value analysis 
Isoabsorptive point :   238.8 
Solvent : Methanol 
Range      :  0.5‐30 μg/mL 
 
4. Nilesh Jain et al. (2010) 
                      “RP- HPLC Method for Simultaneous Estimation of Losartan potassium 
and Amlodipine besylate in Tablet Formulation”. 
Elution  : Isocratic elution. 
Stationary phase :  Microsorb C18 Column (5 μm, 250mm x 4.60mm) 
Mobile phase  : methanol– phosphate buffer (pH 4.0) in the ratio of  
     (70:30) % v/v)  
Temp   : isocratic at 25°C ± 0.5°C 
Flow rate  : 1.2ml/min 
Detector  : PDA detector 
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Wavelength   : 248 nm 
Retention time   : AML- 5.59 + 0.5 min LOP- 4.26 + 0.5 min 
5. Kardile et al. (2010) 
“Simultaneous estimation of Amlodipine besylate and Olmesartan medoxomil 
drug formulations by HPLC and UV-spectrophotometric methods”. 
Elution  : Isocratic elution 
Stationary phase :  Microsorb C18 Column (5 μm, 250mm x 4.60mm) 
Mobile phase  : 0.05 M Pot.dihydrogen phosphate: ACN (50:50 v/v) 
Temp   : isocratic at 25°C ± 0.5°C 
Flow rate  : 1.2ml/min 
Detector  : PDA detector 
Wavelength   : 230-260 nm 
Retention time   : AML- 3.69 OLM -5.36 
6. Chandan Kumar Giri et al. (2010) 
“Simultaneous estimation of nebivolol hydrochloride and amlodipine besylate in 
combined tablet dosage form by q-analysis method”. 
Method  :  Q-analysis method 
Solvent  : Methanol 
Iso-absorptive point   :  268nm and 282nm 
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7. Pournima S patil et al. (2011) 
 “RP-HPLC method for simultaneous estimation of Amlodipine besylate and 
olmesartanmedoxomil from tablet”. 
Solvent   : Methanol 
Method   : Absorption ratio method. 
λmax      : AML- 238 & 360 nm, NBL-281 
Solvent     :  Methanol 
Range     : 2-10µg/ml of Indapamide 
8. Chitlange et al. (2008) 
 “Stability Indicating RP- HPLC Method for Simultaneous Estimation of 
Valsartan and Amlodipine in Capsule Formulation”. 
 
Elution  :           Isocratic elution. 
Stationary phase :  C-18 Column (Kromasil, 250 x 4.6 mm) 
Mobile phase  :     Acetonitrile: (0.02M, pH 3.0) phosphate buffer (56:44v/v)  
Flow rate  :          1ml/min  
Detector  :          UV detector 
Wavelength  :          234 nm 
Retention time  :     AML and VAT was found to be 3.07 and 6.20 min 
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9. Priyanka R Patil et al. (2009) 
                      “RP- HPLC Method for Simultaneous Estimation of  Losartan 
potassium and Amlodipine besylate in Tablet Formulation.” 
Elution  :           Isocratic elution. 
Stationary phase :  C-18 column 
Mobile phase  :     0.02%Triethylamine in water & acetonitrile (60:40) 
Flow rate  :          1ml/min  
Detector  :          UV detector 
Wavelength  :          266 nm 
Retention time  :     10.10 min. 
10. Prasad Rao et al. (2010)              
“HPLC method for quantization of Amlodipine besylate and Metoprolol Succinate 
from bulk drug and pharmaceutical formulations”. 
Elution                :  Isocratic 
Stationary phase    :  Inertsil ODS-CV column 
Mobile phase         : 0.02 M phosphate buffer solution and acetonitrile as
 (80:20) 
Flow rate             :  1 ml/min. 
Detector              :   PDA detector 
Wavelength         :  215 nm. 
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2.2.2 REPORTED METHODS FOR INDAPAMIDE 
1. Pawar et al. (2011)       
“Quantitative Estimation of Indapamide by Ultraviolet Spectrophotometric 
Method”. 
Solvent   : Methanol 
Method   : Simultaneous estimation. 
λmax      : 240 nm 
Solvent     :  Methanol 
 Range     : 2-10µg/ml of Indapamide. 
2. Gaikwad et al. (2010)  
         “Development and validation of UV-Spectrophotometric Method for 
simultaneous   estimation of atenolol and Indapamide in bulk and tablet dosage form”. 
Wavelength  :   Atenolol at 225 nm and Indapamide 240 nm 
Solvent  :  Methanol 
Range      :  6-30 µg/ml for ATN  and 2-10 µg/ml for IND 
3. Patel amit et al. (2011) 
“Method development and validation of simultaneous estimation of 
Telmisartan and Indapamide by reverse phase-high performance liquid 
chromatography in pharmaceutical dosage forms”. 
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Elution                  :  Isocratic 
Stationary phase     :  Amazon C18, 5micron, 150 x 4.6 mm 
Mobile phase       :  KH2po4: Acetonitrile: Methanol (45:25:30v/v/v) 
Flow rate              :  1 ml/min. 
Detector               :   UV detector 
Wavelength         :  285 nm 
Retention time    :  For Indapamide 4.7 minutes and Telmisartan 10.7  
minutes. 
4. Savita S Yadav et al. (2011) 
 “Simultaneous HPTLC analysis of atenolol and indapamide in tablet 
formulation”. 
Stationary phase  :  aluminum foil plates precoated with silica gel 60F254  
Mobile phase      : Toluene: ethyl acetate: methanol: (ammonia 5:3:3:0.1 v/v) 
Wavelength          :  229nm 
Rf Value              :  Indapamide: 0.70, Atenolol: 0.27 
5. Pawar Prachi Vasant et al. (2011) 
 “Development and Validation of  RP-HPLC method for simultaneous 
estimation of Atenolol and Indapamide in pharmaceutical dosage form”.  
Stationary phase  :  Amazon C18, 5micron, 200 x 4.6 mm 
Mobile phase      : Methanol: Water: Diethylamine: Glacial acetic acid 
(70:30:0.12:0.08v/v/v/v) 
Flow rate : 1.2 ml/minute 
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Wavelength          :  240nm 
Retention time             :  Indapamide: 2.758, Atenolol: 1.858 
6. Mohit G Dewani et al. (2011) 
           “Simultaneous estimation of Perindopril Erbumine and Indapamide in bulk 
drug and tablet dosage form by HPTLC”. 
Stationary phase  :  Silica gel 60 F254.  
Mobile phase      :  Dichloromethane: Methanol : Glacial acetic acid in the 
ratio of (9.5:0.5:0.1 v/v/v.) 
Wavelength          :  215nm 
Rf Value              :  Indapamide: 0.50 ± 0.02, Atenolol: 0.30 ± 0.02 
7. Darshana K Modi et al. (2010) 
 “Development and validation of spectrophotometric method for 
simultaneous estimation of Perindopril and Indapamide in combined dosage form by 
Absorbance correction method”. 
Solvent  : Methanol 
Method   : Absorbance correction method. 
λmax      : Perindopril- 210.4nm and Indapamide - 285.8nm 
Solvent     :  Methanol 
Range      : 24 – 56 μg mL-1 of Perindopril 7.5 – 17.5 μg mL-1of 
 Indapamide. 
8. Tushar G Barot et al. (2009) 
 “Validated RP-HPLC methods for simultaneous estimation of Indapamide 
impurity (Methyl Nitrosoindoline) API form”. 
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Elution                  :  Isocratic 
Stationary phase     :  Inertsil ODS 3V, (150 x 4.6 mm, 5μm) 
Mobile phase       :  Triethyl amine pH 2.8: Acetonitrile: Tetrahydrofuran
    (73:7:20 v/v/v)  
Flow rate              :  1.4 ml/min. 
Detector               :   PDA detector 
Wavelength         :  305 nm 
Retention time    :   For Indapamide 16.93 minutes and Methyl   
Nitrosoindoline 14.13 minutes. 
9. Tulja rani et al. (2011)               
 “Validated RP-HPLC Method for simultaneous estimation of Atenolol and 
Indapamide in pharmaceutical formulations”. 
 
Elution                  :  Isocratic 
Stationary phase   :  C18 column (250×4.6 mm, 5 μ) 
Mobile Phase       : Methanol and water (adjusted to pH 2.7 with 1% 
orthophosphoric acid) in the ratio of (80:20 v/v)                              
Flow rate               : 1.0 mL /min 
Detection             : UV-Visible detector  
Wavelength          :  230 nm.  
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10. Jyoti Pai et al. (2011)              
               “Development and Validation of RP-HPLC method for Quantitative 
estimation of Indapamide in Bulk and Pharmaceutical dosage forms”. 
Elution                  :  Isocratic 
Stationary phase     :   C-18 Column (25cm x 4.6 mm i.d.,particle size 5 μm)  
 
Mobile phase       :  Acetonitrile:o-phosphoric acid (0.05%) buffer of pH 3.0
  (60:40v/v) 
Flow rate              :  1 ml/min. 
Detector               :   PDA detector 
Wavelength         :  240 nm 
Retention time    :  For Indapamide 6.76 minutes. 
 
 
 
 
 
 
 
 
 
AIM AND PLAN 
OF WORK 
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3. AIM AND PLAN OF WORK 
3.1 AIM OF WORK 
 The prime importance of drug analysis is to gain information about the 
qualitative and quantitative  compositions of substance and chemical species, that is to 
find out what a substance is composed of and exactly how much. 
 This information guides development of the manufacturing operations and 
therapeutic action of drugs. 
 Standard analytical procedure for newer drugs or its formulation may not be 
available in Pharmacopoeias. Hence it is essential to develop newer analytical 
methods which are accurate, precise, specific, linear, simple and rapid. 
 Amlodipine besylate and Indapamide is a newer combination which is yet to 
be launched in Indian market. 
 Hence, the present study aims to develop simple, precise and accurate methods 
for the determination of Amlodipine besylate and Indapamide by simple UV methods 
and RP-HPLC method. 
3.2 PLAN OF WORK 
 The combination dosage form selected for the present study contains 
Amlodipine besylate and Indapamide in solid oral dosage forms, recently this 
combination of the drugs are introduced into the market. 
Method Development 
 The solubility of the individual drugs was checked from the list of solvents 
present in Indian Pharmacopeia and the common solvents for the drugs are selected. 
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The solvent for both UV spectroscopy and RP-HPLC must be less cost and readily 
available.  
UV Spectroscopy 
 Selection of appropriate wavelength and selection of suitable method 
 Determination  of working concentration range 
 Analysis of  synthetic mixture 
 Simultaneous analysis of the formulation by using the developed method  
RP-HPLC 
 Determination of suitable mobile phase 
 Determination of Stability 
 Determination of suitable detection wavelength by using UV/VIS and PDA 
Detector 
 Optimization of chromatographic conditions 
 Analysis of formulation 
 System suitability testing 
VALIDATION 
 The method to be developed should be validated as per ICH guidelines. The 
various parameters of validation are Accuracy, Precision, Linearity, Range, 
Repeatability, Limit of detection, Limit of Quantification, and Ruggedness. 
 
 
 
MATERIALS AND 
METHODS 
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4.0 MATERIALS AND METHODS 
4.1MATERIAL USED 
DRUGS 
 Amlodipine besylate was generously gifted by Aurbindo Pharmaceuticals 
Hyderabad and Indapamide was generously gifted by Micro labs Ltd., Bangalore. 
FORMULATION USED 
 The formulation NATRILAM containing Amlodipine besylate equivalent to  
5 mg of Amlodipine and 1.5 mg of Indapamide was procured from a local Pharmacy. 
CHEMICAL AND SOLVENTS USED 
Methanol (HPLC grade) 
Acetonitrile (HPLC grade) 
Water (HPLC grade) 
Glacial Acetic acid (Analytical grade) 
Methanol (Analytical grade) and 
Boric acid (Analytical grade) 
Sodium hydroxide (Analytical grade) 
INSTRUMENTS USED 
  Different instruments used to carry out the present work. 
 Shimadzu AUX-220 Digital balance 
Mettler Toledo AB204-S/FACT 
Shimadzu- 1700 Double Beam- UV- Visible spectrophotometer 
 Alliance Waters E2695 modular HPLC System 
 Waters 2489 UV/Visible Detector 
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 Waters 2489 PDA Detector 
 Sonorex Bendelin Digital 10p apparatus 
 Micropipette 
 Elico LI 127 pH meter 
 Milli-Q-Millipore Integral 3 
Specifications (Terms) of Instruments 
Shimadzu AUX- 220 Digital Balance (Shimadzu Instruction Manual) 
 
SPECIFICATIONS 
Weighing capacity 200 gms 
Minimum display 0.1 mg 
Standard deviation ≤ 0.1 mg 
Operation temperature range 5 to 40°C 
 
Double Beam UV- Visible Spectrophotometer (Shimadzu and ELICO Instruction 
Manuals) Model: 
 Shimadzu UV-1700; Double beam UV-Visible Spectrophotometer 
 ELICO SL – 210; Double beam UV-Visible Spectrophotometer 
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Specification Shimadzu UV-1700 Elico SL -210 
Light source 
20 W halogen lamp, Deuterium lamp, 
Light source position automatic 
adjustment mechanism. Built in lamp 
lighting time display function. 
Tungsten halogen lamp 
(W), Deuterium lamp 
(D), 
Light source position 
automatic adjustment 
mechanism. 
Monochromator 
Aberration- correcting concave blazed 
holographic grating. 
Concave holographic 
grating with 1200 lines/ 
mm 
Detector Silicon photodiode Photodiode 
Stray Light 
0.04% or less (220 nm; NAI 10g/lt) 
0.04% or less (340 nm; NaNo2 50g/lt). 
<0.05% T at 220 nm 
with NAI  10g/ lt 
Measurement 
Wavelength 
range 
190 ~ 1100 nm 
 
 
190 ~1100 nm 
Spectral Band 
width 
1 nm or less (190 to 900 nm). 1.8 nm 
Wave length 
Accuracy 
± 0.5 nm on broad automatic 
wavelength calibration mechanism. 
 
± 0.5 nm automatic 
wavelength calibration 
mechanism. 
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Methods 
 In the present work an attempt was made to develop and validate a simple, 
precise and accurate method for the estimation of Amlodipine Besylate and 
Indapamide in pure and in combined tablet dosage form by UV-Spectrophotometry 
and HPLC method. 
4.2.1 UV-SPECTROSCOPY 
Derivative Specrophotometric Method 
 A simple, accurate, rapid and precise, First order derivative 
Spectrophotometric method was developed and validated. The first derivative 
spectrum is a plot of the rate of change of absorbance with wavelength against 
wavelength, i.e. a plot of the slope of the fundamental spectrum against wavelength. 
Recording range 
Absorbance; - 3.99 ~3.99 Abs 
Transmittance; - 399 ~ 399% 
Absorbance; ± 3.000 
Abs 
Photometric 
accuracy 
± 0.004 Abs (at 1.0 Abs). 
± 0.002 Abs (at 0.5 Abs). 
0.005 Abs (at 1.0 Abs). 
0.010 Abs (at 0.5 Abs). 
Operating 
Temperature/ 
Humidity 
 
Temperature range; 15 to 35˚C 
Humidity range; 
35 to 80% (15 to below 35˚C) 
35 to 70% (30 to below 35˚C) 
Temperature range; 15 
to 35˚C 
Humidity range; 
35 to 80% (15 to below 
35˚C) 
35 to 70% (30 to below 
35˚C) 
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Selection of solvent 
The solubility of Amlodipine besylate and Indapamide was determined in 
variety of solvents as per Indian Pharmacopoeia standards. Solubility was carried out 
in polar and non-polar solvents. The common solvent was found to be methanol 
followed by 0.2M Borate buffer - pH 8.0 is chosen as the best and economic solvent 
for the analysis of Amlodipine besylate and Indapamide for the proposed methods. 
From the solubility studies, Methanol followed by dilution with 0.2M Borate buffer 
(pH-8.0) were chosen as solvent for Spectrophotometry, and it was selected on 
account of its ready availability, cost factor, solubility, stability factor and cutoff 
wavelength. 
Preparation of 0.2M Borate buffer – pH 8.0 
 3.09 gm of Boric acid and 3.72 gm of Potassium chloride were dissolved in 
500 ml of water, adjusted to pH 8.0 with 0.2M Sodium hydroxide (about 3.9 ml) and 
diluted with water to 1000 ml. 
Preparation of Amlodipine besylate standard stock solution 
 Weighed accurately about 25 mg of Amlodipine besylate and transferred into 
a 100 mL volumetric flask separately, dissolved in methanol and made up to the 
volume with methanol. These solutions were observed to contain 250 mcg/ml of 
Amlodipine.  
Preparation of Indapamide standard stock solution 
 Weighed accurately about 7.5 mg of Indapamide and transferred into a 100 
mL volumetric flask separately, dissolved in methanol and made up to the volume 
with methanol. These solutions were observed to contain 75 mcg/ml of Indapamide. 
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Selection of Wavelength  
           The standard stock solutions were further diluted with 0.2M Borate buffer-pH 
8.0 and obtained 10 µg/ml. The solution was scanned between 200 and 400 nm ranges 
using methanol followed by Borate buffer. For derivative Spectroscopic method, the 
zero order spectrums was derivatised to first order and the wavelength 339.0  was 
selected for the estimation of Amlodipine besylate which is zero crossing for 
Indapamide where as 293.0 nm was selected for the estimation of Indapamide which 
is zero crossing for Amlodipine besylate. The  calibration  curve  for  all the  
wavelengths  were  constructed  by  plotting  absorbance  Vs  concentration  for  
simultaneous equation   and  ΔA/Δλ  for  first  order  derivative  method. The stability 
was performed by measuring the absorbance of same solution at different time 
intervals. It was found that Amlodipine besylate and Indapamide were stable for more 
than 3 hours. 
Stability studies 
            The Stability studies were performed by measuring the absorbance of same 
solution at different time intervals. It was observed that Amlodipine besylate and 
Indapamide in the specified solvent were stable for more than 3 hours at their 
wavelength maxima. 
Preparation of calibration graph  
For Amlodipine besylate 
          132.10 Equivalent of Amlodipine besylate working standard were weighed and 
transferred into 25 ml volumetric flasks separately. Dissolved in Methanol and made 
up to the volume with methanol (3750 µg/ml). 1ml of the solution was transferred into 
a 25 ml volumetric flask and made up to the required volume with 0.2M Borate buffer 
pH 8.0 to get the concentration 150 µg/ml. 1–6 ml were transferred into a series of 10 
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ml volumetric flasks and made up to the mark with Borate buffer. The absorbance of 
different concentration solutions was measured at 339.0 nm against blank. The 
calibration curve was plotted using concentration against absorbance. The solutions 
were found to be linear with the concentration range of 15 – 90 µg/ml. The procedure 
was repeated for three times. 
For Indapamide 
31.25 mg of Indapamide raw material was weighed and transferred into 25 ml 
volumetric flask. Dissolved in methanol and made up to the volume with methanol 
(1250 µg/ml). 1ml of the solution was transferred into a 25 ml volumetric flask and 
made up to the required volume with 0.2M Borate buffer–pH 8.0 to get the 
concentration 50 µg/ml. From the aliquots of stock solution of Indapamide 1–6 ml 
were transferred into a series of 10 ml volumetric flasks and made up to the mark with 
Borate buffer. The absorbance of different concentration solutions was measured at 
293.0 against blank. The calibration curve was plotted using concentration against 
absorbance. The solutions were found to be linear with the concentration range of 5 – 
30 µg/ml. The procedure was repeated for three times. 
Quantification of formulation 
           Twenty tablets of (NATRILAM containing Amlodipine besylate 5 mg of 
Amlodipine and 1.5 mg of Indapamide, were weighed accurately. The average weight 
of tablets was found and powdered. The tablet powder equivalent to 25 mg of 
Amlodipine  was weighed transferred into a 100 ml volumetric flask and added a 
minimum quantity of Methanol to dissolve the substance and made up to the volume 
with the same (250 µg/ml). The solution was sonicated for 15 minutes, centrifuged for 
15 minutes at 100 rpm and filtered through Whatmann filter paper No. 41. From the 
clear solution, further dilutions were made by diluting 1 ml of the solution into a 100 
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ml volumetric flask and made up to the required volume with 0.2M Borate buffer to 
get the concentration of 25 µg/ml of Amlodipine besylate 7.5 µg/ml of Indapamide. 
The absorbance measurements were made six times for the formulation at 339.0 nm 
and 293.0 nm. Amlodipine Besylate and Indapamide were found by constructing First 
order derivative spectrophotometric method. 
 
Recovery studies 
 The recovery experiment was performed by adding known concentrations of      
Amlodipine besylate and Indapamide raw material to the 50% preanalyzed   
formulation. Standard Amlodipine besylate and Indapamide in the range of 15 µg/ml, 
22.5 µg/ml, 30 µg/ml, 37.5 µg/ml, 45 µg/ml, 52.5 µg/ml and 5 µg/ml, 7.5 µg/ml, 10 
µg/ml, 12.5 µg/ml, 15 µg/ml, 17.5µg/ml was added to the 50% preanalyzed 
formulation into a series of 10 ml  volumetric flasks, diluted with Borate buffer and 
made up to the mark with the same solvent. The contents were sonicated for 15 
minutes. After sonication, the solutions were filtered through Whatmann filter paper 
No. 41. The absorbance of the resulting solutions was measured at their selected 
wavelengths for the determination of Amlodipine besylate and Indapamide 
respectively. The amount of each drug recovered from the formulations was 
calculated by using first order derivative spectrophotometric method. The procedure 
was repeated for three times for each concentration. 
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Validation of developed method  
Linearity 
           A calibration curve was plotted between concentration and absorbance. 
Amlodipine besylate was linear with the concentration range of 15 – 90 µg/ml at 
339.0 nm and Indapamide showed the linearity in the range of 5 – 30 µg/ml at 293.0 
nm. 
Accuracy  
           Accuracy of the method was confirmed by recovery studies. To the pre 
analyzed formulation, a known quantity of working standard of Amlodipine besylate 
and Indapamide were added and the procedure was followed as per the analysis of 
formulations. The amount of each drug recovered was calculated. This procedure was 
repeated for three times for each concentration. The % RSD was calculated. 
Precision 
           The repeatability of the method was confirmed by the analysis of formulations 
and repeated for six times with the same concentration. The amount of each drug 
present in the tablet formulations was calculated. The percentage RSD was calculated.  
The intermediate precision of the method was confirmed by intraday and inter-day 
analysis i.e. the analysis of formulations was repeated three times in the same day and 
one time three successive days. The amount of drugs was determined and percentage 
RSD also calculated. 
Ruggedness 
           Ruggedness of the method was confirmed by the analysis of formulations by 
using the different analysts with the different instruments. The amount and % RSD 
were calculated. 
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Limit of detection (LOD) and Limit of Quantification (LOQ) 
 Preparation of calibration curve from the serial dilutions of standard was 
repeated for six times. The Limit of detection and limit of quantification was 
calculated by using the average value of slope and standard deviation of the intercept. 
 
4.2.2 RP-HPLC METHOD DEVELOPMENT AND OPTIMIZATION OF 
CHROMATOGRAPHIC CONDITIONS 
Selection of chromatographic method 
 Proper selection of the method depends upon the nature of sample, polarity, 
molecular weight, Pka value and solubility. The drugs Amlodipine besylate and 
Indapamide for the present study were polar. So, Reverse Phase Chromatographic 
technique was selected by using C18 column as a stationary phase with different 
mobile phase. 
Selection of mobile phase and wavelength 
 Different mixtures of mobile phase with different ratios were selected and 
their chromatograms were recorded. As a result Acetonitrile: Methanol: 0.04M 
Phosphate buffer-pH 3.0 (25:30:45 v/v/v) was selected as mobile phase.  The two 
drugs were eluted with sharp peak and with better resolution while using the above 
ratio.  Hence this mobile phase was used to optimize the chromatographic conditions.  
 And  scanned  in  the  UV region  of  200 – 400 nm  and  recorded  the 
spectrums. It was found that two drugs have marked absorbance at 240.0 nm and can 
be effectively used for the estimation of two drugs without interference. Therefore  
240.0 nm  was  selected  as detection wavelength for estimation of  two  drugs by RP 
– HPLC  method  with  an  Isocratic elution  technique. 
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Stability of sample solutions  
 Solutions  of  Amlodipine besylate  and  Indapamide (10 µg/ml) absorbance  
were  checked  for  their  stability at  240 nm and  it  was  found  that  two drugs  were  
stable  for   three  hours. 
OPTIMIZATION OF CHROMATOGRAPHIC CONDITIONS 
Initial separation conditions  
      The  following  chromatographic  conditions  were  preset  initially  to  get  better 
resolution  of  Amlodipine besylate and Indapamide. 
Mode of operation - Isocratic 
Stationary phase - C18 column (250 mm x5.6 mm i.d. 5µm) 
Mobile phase - Acetonitrile: Methanol: Phosphate buffer - pH 3.0   
Proportion of mobile phase - 30:40:30 % v/v/v 
Detection wavelength - 240 nm 
Flow rate - 1.0 mL/min 
Temperature - Ambient 
Sample load - 20 µL 
Operating pressure - 190 kgf 
Method - External Standard Calibration method 
The  mobile  phase  was  primarily  allowed  to  run  for  20  minutes  to  
record a steady baseline. Mixture of Solutions of   Amlodipine besylate and 
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Indapamide were injected and the respective chromatogram was recorded.  It was 
found that both   Amlodipine besylate and Indapamide were spitted, for these reason 
different ratios of mobile phase with different solvents were tried to obtain good 
chromatogram with acceptable system suitability parameters. 
Selection of mobile phase 
  A mobile phase contains Acetonitrile: Methanol: (0.04M) Phosphate buffer 
pH 3.0 was selected. 
The ratio of the mobile phase is 
S. No Mobile phase Observation 
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Acetonitrile: Methanol: (0.04M) 
Phosphate buffer-pH 3.0  
(25:30:45 v/v/v) 
Both  the  Amlodipine besylate and 
Indapamide were eluted with sharp peak 
 
Optimized chromatographic conditions 
 The following optimized conditions were employed for analysis Amlodipine 
besylate and Indapamide by Isocratic RP – HPLC method. 
Mode of operation -  Isocratic 
Stationary phase -   C18 column (250 mm x 5.6 mm i.d. 5µm) 
Mobile phase - Acetonitrile: Methanol: Phosphate buffer - pH 3.0   
Diluent -  Methanol 
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Proportion of mobile phase - 25:30:45 % v/v/v 
Detection wavelength    - 240 nm 
Flow rate - 1.0 mL/min 
Temperature - Ambient 
Sample load - 20 µL 
Operating pressure - 121kgf 
Method - External Standard Calibration method 
Preparation of Mobile phase 
Preparation of standard stock solution 
 100 mg and 30 mg of Amlodipine Besylate and Indapamide were weighed 
accurately and transfer in to a 100 ml standard flask. The volume was made up to 
mark with methanol to get 1000 µg/ ml and 300 µg/ml of Amlodipine besylate and 
Indapamide respectively. 
Preparation of Calibration graph 
  From the above stock solution, 8-12 ml was transferred into the series of five 
100 ml volumetric flask and made upto the volume with mobile phase to get the 
concentration 80-120 µg/ml of Amlodipine besylate and 24-36 µg/ml of Indapamide. 
The solutions were injected and the chromatograms were recorded at 240.0 nm.  The 
above concentration range was found to be linear and obeys Beer’s law. The 
procedure was repeated for six times. The peak areas were plotted against 
concentration and the calibration curve was constructed. 
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Estimation of Amlodipine besylate and Indapamide in tablet formulation 
 Estimation of Amlodipine besylate and Indapamide in tablet formulation by 
RP – HPLC was carried out using optimized chromatographic conditions. Twenty 
tablets of formulation (Containing Amlodipine besylate equivalent to Amlodipine 
5mg and Indapamide 1.5 mg) were weighed accurately. The average weight of tablets 
was found and powdered. The tablet powder equivalent to 25 mg of Amlodipine was 
weighed  and  transferred  into a 50 mL volumetric flask and  added  a  minimum  
quantity  of  methanol  to  dissolve  the  substance  and  the content was sonicated for  
15 minutes, and made up to the volume with methanol then filtered through  
Whatmann  filter  paper No. 41. From the clear solution, the dilutions were made by 
diluting 10 mL into 50 mL with mobile phase and to get the concentration of 100 
µg/ml of Amlodipine and 30 µg/ml of Indapamide theoretically. This solution is used 
for further analysis. 
Assay Procedure  
 From the above stock solution, 10 mL was pipetted into six different 100 mL 
volumetric flasks and made up the volume with mobile phase to obtain 100 µg/ml 
solution of Amlodipine and 30 µg/ml of Indapamide. A steady base line was recorded 
with optimized chromatographic conditions. After the  stabilization  of   base  line for 
20 minutes, six  test  solutions of  formulation  were  injected  and recorded  the  
chromatograms.  The concentration of each test solution was determined by using 
slope and intercept values from the calibration graph.  
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Recovery Experiments  
a) Preparation of Amlodipine besylate and Indapamide raw material stock 
solution 
 An  accurately  weighed  quantity  of  100 mg  of  Amlodipine besylate and 30 
mg of Indapamide were transferred in to a 100 mL volumetric flask and added  
sufficient  methanol  to  dissolve  the  substance  and  made up to the mark with the 
same solvent.  The above solutions were further diluted to get final concentration of 
1000 µg/ml of Amlodipine besylate and 300 µg/ml of Indapamide. 
b) Preparation of Placebo solution 
 0.9825 g of placebos were accurately weighed and transferred in to a 100 ml 
flask and added sufficient volume of methanol to dissolve the substance and made up 
to the mark with same. From the above solution, 10 ml was transferred in to a 100 ml 
flask and made up to mark with mobile phase. 
c) Procedure 
 To each 10 mL of 50 % preanalysed placebos solution  added, 8, 10 and 12 
mL of Amlodipine besylate and Indapamide raw material stock solutions into three 
different 100 mL volumetric  flasks  and  made  up  to  the  mark  with mobile phase. 
The procedure was repeated as per analysis of   placebo.  The  quantity  of  raw 
material  recovered  was  calculated  by  using  slope  and  intercept  values  from  the  
calibration  graph. 
Limit of Detection and Limit of Quantification 
Preparation of calibration curve for the serial dilution of standard was repeated 
for six times. The limit of detection and limit of quantification were calculated by    
using the average value of slope and standard deviation of response (Intercept). 
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System suitability studies 
 The   system   suitability   studies conceded as per ICH guidelines and USP. 
The   parameters such as capacity factor, tailing factor, asymmetry factor, number of 
theoretical plate and resolution were calculated. 
 
 
 
 
 
 
 
 
 
RESULTS AND 
DISCUSSION 
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5. RESULTS AND DISCUSSION 
  Estimation of multiple drugs in formulations have advantage over the 
methods which are time consuming and also usage of solvent is minimized. Two 
simple, rapid, precise and accurate Spectrophotometric  methods  and  an  isocratic  
RP – HPLC  method  were developed and validated for the  estimation  of  
Amlodipine besylate and  Indapamide  in  pure form and in combined tablet dosage 
form. The methods employed which are 
 UV Spectrophotometric methods 
  Derivative Spectrophotometric method 
 RP – HPLC method 
5.1 DERIVATIVE SPECTROPHOTOMETRIC METHOD 
A simple, accurate and precise Derivative spectrophotometric method was 
developed and validated for the simultaneous estimation of Amlodipine besylate and 
Indapamide in combined dosage form. The drugs were identified by the melting point 
and IR spectrum, the IR spectrum of Amlodipine besylate and Indapamide are given 
in figures 1 and 2, respectively. The solubility of the drugs in various polar and non 
polar solvents was checked as per the I.P specifications. The common solvent used for 
estimation of Amlodipine besylate and Indapamide was chosen is methanol followed 
by 0.2M Borate buffer - pH 8.0. The solubility profile of Amlodipine besylate and 
Indapamide are given in Tables 1 and 2 respectively. 
 The sample solutions of 10 µg/ml of Amlodipine besylate and Indapamide in 
methanol prepared individually and the solutions were scanned in UV region in the 
wavelength range from 200 and 400 nm by using methanol and 0.2M Borate buffer 
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pH 8.0 as blank. The zero order spectrums were derivatised into first order derivative 
spectrum. The first order derivative spectrum of Amlodipine besylate and Indapamide 
was recorded as shown in Figure 3, 4 and 5 respectively.  From the spectrum, 339.0 
nm and 293.0 nm were selected for the estimation of Amlodipine besylate and 
Indapamide respectively without any interference. At 293.0 nm, Amlodipine besylate 
has zero absorbance. At 339.0 nm, Indapamide has zero absorbance value. Hence 
these two wavelengths were selected for the analysis of Amlodipine besylate and 
Indapamide, respectively.  Different aliquots of Amlodipine besylate and Indapamide 
were prepared in the concentration range of 15 - 90 µg/ml and 5- 30 µg/ml, 
respectively. The absorbances of these solutions were measured at 339.0 nm and 
293.0 nm in the first order derivative spectrum for Amlodipine besylate and 
Indapamide, respectively. The plotted graphs are shown in Figure 6 and 7 for 
Amlodipine besylate and Indapamide,   respectively. The preparation of calibration 
curve was repeated for six times for each drug at their selective wavelength. The 
calibration curve was plotted using concentration against absorbance. The optical 
parameters like, Sandell’s sensitivity,  Molar absorptivity, correlation coefficient,  
slope,  intercept,  LOD,  LOQ  and  Standard error  were  calculated  for  the two 
drugs. The correlation coefficient for the two drugs was found to be above 0.999. This 
indicates that the two drugs obey Beer’s law in the selected concentration range. 
Hence the concentrations were found to be linear. The results are shown in Table 3. 
 Formulated tablets containing 5 mg of Amlodipine besylate and 1.5 mg of 
Indapamide was selected for analysis. The solution contains 25 µg/ml of Amlodipine 
besylate was prepared (nominal concentration in the calibration curve of Amlodipine 
besylate), which is also contains 7.5 µg/ml of Indapamide, the absorbance of these 
solutions were measured at 339.0 nm and 293.0 nm. The amount of six test solutions 
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was determined. The percentage label claim present in tablet formulation was found 
to be 98.60 ± 0.6196 and 99.325 ± 1.2554 for Amlodipine besylate and Indapamide, 
respectively. The amount present in tablet formulation was in good concord with the 
label claim and the % RSD values were found to be 0.6247 and 1.26398 for 
Amlodipine besylate and Indapamide, respectively. The results of analysis are shown 
in Table 4.  The low % RSD values indicate that the method has good precision.  
 Further the precision of the method was confirmed by Intra-day and Inter-day 
analysis. The analysis of formulation was carried out for three times in the same day 
and one time in the three consecutive days. The % RSD value of Intraday and Inter 
day analysis are 0.7026 and 0.1175 for Amlodipine besylate, 1.1703 and 1.1783 for 
Indapamide, respectively.  The results of analysis are shown in Table 5. Hence the 
precision was confirmed. The results showed that the precision of the method was 
further confirmed. 
 The developed method was validated for Ruggedness. It refers to the specific 
of one lab to multiple days which may include multiple analysts, multiple instruments 
and different sources of reagents and so on. In  the  present  work  it  was  confirmed  
by  different  analysts. The % RSD value by analyst 1 and  analyst  2  were  found  to 
be  0.1174 and  0.1178 for Amlodipine besylate and 0.1783 and 1.1703 for  
Indapamide,  respectively.  The low % RSD values indicate that the developed 
method was more rugged. The results are shown in Table 6. 
 The accuracy of the method was performed by recovery studies. To the 
preanalyzed formulation, a known quantity of Amlodipine besylate and Indapamide 
raw material solutions were added at different levels. The absorbance of the solutions 
was measured and the percentage   recovery was calculated.  The  percentage  
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recovery  was  found  to  be in the range of 98.14 - 99.22%  for Amlodipine besylate,  
and  99.24 – 100.56%  for  Indapamide.  The  low  % RSD  value  for  the two  drugs  
indicates  that  this  method  is  very accurate. The recovery data is shown in Table 7.  
 
5.2 RP – HPLC METHOD 
 An exertion has been made for a simple, rapid, accurate and precise method 
for the estimation of Amlodipine besylate and Indapamide pure form and in 
formulation by an isocratic RP – HPLC method. 
 The  solutions  of  10 µg/ml of   Amlodipine besylate and Indapamide in 
mobile phase  Acetonitrile: Methanol: Phosphate buffer - pH 3.0 (25:30:45 % v/v) 
were  prepared  and  the  solutions were scanned in the  range  of  200 – 400 nm. It  
was  found  that the  two  drugs  have  marked  absorbance  at 240 nm and can be 
effectively used for estimation of two drugs without interference. Therefore 240 nm 
was selected  as  detection  wavelength  for  estimation  of  two  drugs  by RP – HPLC 
method with an isocratic  elution  technique  and  it  was  found  that  the two  drugs 
are stable for three hours. The Spectral confirmation of Amlodipine besylate and 
Indapamide were shown in Figure 8 and 9 respectively, and the overlain spectrum of 
Amlodipine besylate and Indapamide in mobile phase is given in Figure 10. 
 The optimization was done by changing the composition of mobile phase 
consists of Acetonitrile: Methanol: Phosphate buffer with different ratio was initially 
attempted and chromatograms were recorded.  These are shown in Figure 11 and 12.  
Finally the mobile phase consists of Acetonitrile: Methanol: 0.04M Phosphate buffer 
pH 3.0 (25:30:45 v/v/v). After calculating all system suitability parameters 
Acetonitrile: Methanol:  Phosphate buffer pH 3.0 with the ratio of (25:30:45 % v/v/v) 
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at a flow rate of 1.0 mL/min was selected and the optimized chromatogram is shown 
in Figure 13. The retention time of Amlodipine besylate and Indapamide, were found 
to be 8.6 and 6.5, respectively.  The retention  time  between  two  drugs  indicate  that  
the  drugs  were separated with better resolution of 2.07 Amlodipine besylate and 
Indapamide. The system suitability parameters for the optimized chromatogram are 
shown in Table 12. 
 With the optimized chromatographic conditions, stock solutions of 
Amlodipine besylate and Indapamide were prepared as the mixture of Amlodipine 
besylate and Indapamide in the concentration range of   80-120 µg/ml of Amlodipine 
besylate, 24-36 µg/ml of Indapamide. 20 µL of each solution was injected and 
recorded the chromatograms at 240 nm. The chromatograms are shown in Figure 14 - 
18. The calibration curve was plotted using concentration against peak area.  The 
procedure was repeated for three times.  The  correlation  co-efficient  was  found  to  
be  above  0.999  for  the  two  drugs. The calibration graph of Amlodipine besylate 
and Indapamide are shown in Figure 19 and 20, respectively.  The optical parameters 
like  correlation coefficient,  slope,  intercept,  LOD,  LOQ  and  Standard error  were  
calculated  for  the two drugs. The above optical parameters were shown in Table 8. 
 Formulated tablets containing Amlodipine besylate equivalent to 5 mg of 
Amlodipine   and 1.5 mg of Indapamide was selected for analysis. The ostensible 
concentration 100 µg mL-1 of Amlodipine Besylate, which is also contains 30 µg mL-1 
of Indapamide in the mobile phase was prepared. 20 µL of each solution was injected 
and chromatograms were recorded. The percentage purity was found to be 100.86 ± 
0.7023 and 100.61 ± 0.4471 for Amlodipine besylate and Indapamide, respectively. 
The precision of the method was confirmed by repeatability of formulation for six 
times and the chromatograms are shown in Figure 21 – 26. The % RSD was found to 
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be 0.6963 and 0.4444 for Amlodipine besylate and Indapamide, respectively. It 
indicates that the method has good precision. The data is shown in Table 9. 
The ruggedness of the method was validated by using different analysts and 
different instruments. The %RSD for analyst 1 and analyst 2 were found to be 
0.141322 and 0.748171 for Amlodipine besylate, 0.556417 and 1.230012 for 
Indapamide, respectively. The results of the analysis are given in Table 11. 
 The accuracy of the method was performed by recovery studies. To the 
preanalysed placebos, a known quantity of Amlodipine besylate and Indapamide raw 
material solutions were added at different levels, injected the solutions. The 
chromatograms were recorded as shown in the Figure 27–29. The percentage  
recovery  was  found  to  be  in  the  range  between  98.71 –100.06 %  for  
Amlodipine besylate  and  98.85– 100.36%  for Indapamide. The % RSD was found 
to be 1.783 and 0.650 for Amlodipine besylate and Indapamide, respectively. The low 
% RSD values for recovery indicated that the method was found to be accurate. The 
values are given in the Table 10.  
  All the above parameters with the ease of operation ensure that the 
proposed methods could be applied for the routine analysis of Amlodipine besylate 
and Indapamide in pure form and in tablet dosage forms. 
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6. SUMMARY AND CONCLUSION 
Simple, rapid, precise and accurate UV Spectrophotometric method and RP-
HPLC method were developed and validated for the estimation of Amlodipine 
besylate and Indapamide in tablet dosage form.  
6.1. UV SPECTROSCOPIC METHODS 
From the solubility profile and stability studies, methanol followed by Borate 
buffer pH 8.0 was chosen as a common solvent for the estimation of Amlodipine 
besylate and Indapamide. The sample solutions of 10 µg/ml of Amlodipine besylate 
and Indapamide in methanol followed by Borate buffer - pH 8.0 prepared individually 
and the solutions were scanned in the wavelength range from 200 to 400 nm by using 
methanol and 0.2M Borate buffer - pH 8.0 as blank. The overlaid spectra of mixture 
of Amlodipine besylate and Indapamide were recorded. From the spectra, 339.0 nm 
for Amlodipine besylate and 293.0 nm for Indapamide were selected as wavelength.   
          The same spectrums were derivatised and 339.0 nm selected for detection of 
Amlodipine besylate where Indapamide shows zero crossing and also 293.0 nm 
selected for detection Indapamide where Amlodipine besylate shows zero crossing. 
The percentage label claim present in the formulation was found to be 98.60 ± 0.6196 
and 99.325 ± 1.2554 for Amlodipine besylate and Indapamide respectively. The 
percentage recovery was found to be in the range of 98.03- 99.67% for Amlodipine 
besylate, and 98.30 – 101.10% for Indapamide.  
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6.2. RP – HPLC METHOD 
 In RP-HPLC method, mobile phase used  is  Acetonitrile: Methanol: 0.04M 
Phosphate buffer - pH 3.0 (25:30:45 v/v/v) with flow rate of 1.0 mL per min, the 
retention time of Amlodipine besylate and Indapamide were found to be 8.77 and  
6.62, respectively  at 240.0 nm. 
            The percentage purity was found to be 100.86 ± 0.7023 and 100.61± 0.4471 
for Amlodipine besylate and Indapamide, respectively. The precision of the method 
was confirmed by repeatability of formulation for six times. The accuracy of the 
method was confirmed by recovery studies. The percentage recovery was found to be 
in the range between 100.06 and 101.65 % for Amlodipine besylate and 100.4 and 
101.39% for Amlodipine besylate and Indapamide. The low % RSD values for 
recovery indicated that the method was found to be accurate. 
 Simple, rapid and accurate UV Spectroscopic (First order derivative method) 
and an isocratic RP – HPLC methods showed excellent sensitivity, reproducibility, 
accuracy, and repeatability, which is evidenced by low percentage relative standard 
deviation. The results obtained in recovery studies were indicating that there is no 
interference from the excipients used in the formulation.  By comparing two methods, 
UV Spectroscopic methods were found to be economic when compared to RP-HPLC. 
Hence it is suggested that the proposed UV Spectroscopic and an isocratic RP-HPLC 
methods can be effectively applied for the routine analysis of Amlodipine besylate 
and Indapamide in bulk and in tablet formulation. The results drawn are presented as 
in Figures/Tables at an appropriate place i.e. in the form of sequence viz. 
identification of samples to recovery Studies including system suitability test 
parameters.
FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE - 1 
IR SPECTRUM OF AMLODIPINE BESYLATE 
 
 
 
 
 
 
 
 
 
FIGURE - 2 
IR SPECTRUM OF INDAPAMIDE 
 
 
 
 
 
 
 
 
 
 
FIGURE - 3 
FIRST ORDER DERIVATIVE UV SPECTRUM OFAMLODIPINE 
BESYLATE IN METHANOL FOLLOWED BY 
0.2M BORATE BUFFER - pH 8.0 
 
 
 
 
 
 
 
 
FIGURE - 4 
FIRST ORDER DERIVATIVE UV SPECTRUM OF INDAPAMIDE IN 
METHANOL FOLLOWED BY 0.2M BORATE BUFFER - pH 8.0 
 
 
 
 
 
 
 
 
FIGURE – 5 
OVERLAIN FIRST ORDER DERIVATIVE UV SPECTRUM OF 
AMLODIPINE BESYLATE AND INDAPAMIDE IN METHANOL 
FOLLOWED BY 0.2M BORATE BUFFER - pH 8.0 
 
 
 
 
 
 
 
 
FIGURE - 6 
CALIBRATION CURVE OF AMLODIPINE BESYLATE IN METHANOL 
FOLLOWED BY BORATE BUFFER AT 339.0                                                                                     
(FIRST ORDER DERIVATIVE SPECTROPHOTOMETRIC METHOD) 
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FIGURE-7 
CALIBRATION CURVE OF INDAPAMIDE IN METHANOL FOLLOWED 
BY BORATE BUFFER AT 293.0                                                                                     
(FIRST ORDER DERIVATIVE SPECTROPHOTOMETRIC METHOD) 
 
 
  
 
 
 
 
 
0
0.0034
0.0065
0.0097
0.0128
0.0159
0.0189
0
0.002
0.004
0.006
0.008
0.01
0.012
0.014
0.016
0.018
0.02
0 5 10 15 20 25 30 35
A
B
SO
R
B
AN
C
E
CONCENTRATION [µg/ml]
CALIBRATION CURVE 
FIGURE - 8 
SPECTRAL CONFIRMATION OF AMLODIPINE BESYLATE IN 
METHANOL FOLLOWED BY MOBILE PHASE AT 240.0 nm 
 
 
 
FIGURE - 9 
SPECTRAL CONFIRMATION OF INDAPAMIDE IN METHANOL 
FOLLOWED MOBILE PHASE AT 240.0 nm  
 
 
 
 
FIGURE -10 
OVERLAIN SPECTRUM OF AMLODIPINE BESYLATE AND 
INDAPAMIDE IN METHANOL AND MOBILE PHASE AT 240.0 nm 
 
 
 
 
FIGURE -11 
CHROMATOGRAM OF AMLODIPINE BESYLATE AND INDAPAMIDE IN 
METHANOL AND ACETONITRILE (50: 50 % v/v)
 
 
FIGURE-12 
CHROMATOGRAM OF AMLODIPINE BESYLATE AND INDAPAMIE IN 
ACETONITRILE, METHANOL AND PHOSPHATE BUFFER - pH 3.0 
(30:40:30 % v/v/v) 
FIGURE-13 
OPTIMIZED CHROMATOGRAM OF AMLODIPINE BESYLATE AND 
INDAPAMIDE IN ACETONITRILE, METHANOL AND PHOSPHATE 
BUFFER-pH 3.0 (30:35:45 % v/v/v) 
 
 
  
 
 
FIGURE-14 
LINEARITY CHROMATOGRAM OF AMLODIPINE BESYLATE AND 
INDAPAMIDE (80, 24 µg/ml) 
 
  
 
FIGURE-15 
LINEARITY CHROMATOGRAM OF AMLODIPINE BESYLATE AND 
INDAPAMIDE (90, 27 µg/ml) 
 
  
FIGURE-16 
LINEARITY CHROMATOGRAM OF AMLODIPINE BESYLATE AND 
INDAPAMIDE (100, 30 µg/ml) 
 
  
FIGURE-17 
LINEARITY CHROMATOGRAM OF AMLODIPINE BESYLATE AND 
INDAPAMIDE (110, 33 µg/ml) 
 
  
FIGURE-18 
LINEARITY CHROMATOGRAM OF AMLODIPINE BESYLATE AND 
INDAPAMIDE (120, 36 µg/ml) 
  
 
FIGURE-19 
CALIBRATION CURVE OF AMLODIPINE BESYLATE IN MOBILE PHASE 
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FIGURE-20 
CALIBRATION CURVE OF INDAPAMIDE IN MOBILE PHASE 
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FIGURE-21 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (NATRILAM) 
REPEATABILITY - 1
 
  
 
FIGURE-22 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (NATRILAM) 
REPEATABILITY - 2
 
  
 
FIGURE-23 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (NATRILAM) 
REPEATABILITY - 3
 
  
 
FIGURE-24 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (NATRILAM) 
REPEATABILITY – 4 
  
 
FIGURE-25 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (NATRILAM) 
REPEATABILITY – 5 
 
  
 
FIGURE-26 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION  (NATRILAM) 
REPEATABILITY - 6 
 
  
 
FIGURE-27 
CHROMATOGRAM FOR RECOVERY STUDIES (80%)  
 
  
FIGURE-28 
CHROMATOGRAM FOR RECOVERY STUDIES (100%)  
 
 
  
 
 
FIGURE-29 
CHROMATOGRAM FOR RECOVERY STUDIES (120%)  
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TABLE-1 
SOLUBILITY DATA FOR AMLODIPINE BEYSLATE IN POLAR AND NON 
POLAR SOLVENTS 
S.NO SOLVENT SOLUBILITY SOLUBILITY STATUS 
1. Acetone 10 mg in 30 µl Freely soluble 
2. Acetonitrile 10 mg in 1200 µl Slightly soluble 
3. Benzene More than 100 ml Practically insoluble 
4. Carbon tetra Chloride 10 mg in 10 ml Practically insoluble 
5. Chloroform 10 mg in 10 µl Freely soluble 
6. Dichloro methane 10 mg in 20 µl Freely soluble 
7. Diethyl ether 10 mg in 3000 µl Slightly soluble 
8. Dimethyl formamide 10 mg in 50 µl Freely soluble 
9. Distilled water 10 mg in 8000 µl Slightly soluble 
10. Ethanol 10 mg in 10 µl Freely soluble 
11. Ethyl Acetate 10 mg in 20 µl Freely soluble 
12. Glacial acetic acid 10 mg in 20 µl Freely soluble 
13. Hexane More than 100 ml Practically insoluble 
14. Hydrochloric acid (0.1 M) 10 mg in 20 ml Very slightly soluble 
15. Isopropyl alcohol 10 mg in 5000 µl Slightly soluble 
16. Methanol 10 mg in 15 µl Freely soluble 
17. n-butanol 10 mg in 1300 µl Slightly soluble 
18. Petroleum ether More than 100 ml Practically insoluble 
19. Sodium hydroxide (0.1 M) More than 100 ml Practically insoluble 
20. Toluene More than 100 ml Practically insoluble 
 
 
TABLE-2 
SOLUBILITY DATA FOR INDAPAMIDE IN POLAR AND NON POLAR 
SOLVENTS 
S.NO SOLVENT SOLUBILITY SOLUBILITY STATUS 
1. Acetone 10 mg in 10 µl Freely soluble 
2. Acetonitrile 10 mg in 30 µl Freely soluble 
3. Benzene More than 100 ml Practically insoluble 
4. Carbon tetra Chloride 10 mg in 10 ml Practically insoluble 
5. Chloroform 10 mg in 3 ml Slightly Soluble 
6. Dichloro methane 10 mg in 10 ml Slightly soluble 
7. Diethyl ether 10 mg in 10 ml Slightly soluble 
8. Dimethyl formamide 10 mg in 30 µl Freely soluble 
9. Distilled water More than 100 ml Practically insoluble 
10. Ethanol 10 mg in 90 µl Freely Soluble 
11. Ethyl Acetate 10 mg in 100 µl Soluble 
12. Glacial acetic acid 10 mg in 90 µl Freely soluble 
13. Hexane More than 100 ml Practically insoluble 
14. Hydrochloric acid (0.1 M) 10 mg in 3000 µl Slightly insoluble 
15. Isopropyl alcohol 10 mg in 3000 µl Slightly soluble 
16. Methanol 10 mg in 30 µl Freely soluble 
17. n-butanol 10 mg in 600 µl Soluble 
18. Petroleum ether More than 100 ml Practically insoluble 
19. Sodium hydroxide (0.1 M) 10 mg in 1000 µl Sparingly soluble 
20. Toluene More than 100 ml Practically insoluble 
 
 
TABLE-3 
OPTICAL CHARACTERSTICS OF AMLODIPINE BESYLATE AND 
INDAPAMIDE BY FIRST ORDER DERIVATIVE SPECTROSCOPIC METHOD 
 
 
PARAMETERS 
 
AMLODIPINE 
BESYLATE 
AT 339.0 nm* 
 
INDAPAMIDE AT 
293.0 nm* 
 
Beers law limit (µg mL-1) 
 
15-90 (µg mL-1) 
 
5-30 (µg mL-1) 
 
Molar absorptivity 
 
 
176.6787 
 
 
236.2281 
 
 
Sandells sensitivity 
( µg/cm2/0.001 A.U) 
 
 
3.032491 
 
 
 
1.590909 
 
 
Correlation coefficient (r) 
 
0.999842 
 
 
0.999876 
 
 
Regression equation 
( y= mx + c) 
 
Y = 0.0033x - (-)0.00018 
 
Y = 0.0006 x 0.000171 
 
 
Slope (m) 
 
0.00033 
 
 
0.000629 
 
 
Intercept (c) 
 
-0.00018 
 
 
0.000171 
 
 
LOD (µg mL-1) 
 
0.3973 
 
 
0.2177 
 
 
LOQ (µg mL-1) 
 
1.2041 
 
 
0.6597 
 
*Mean of six observations 
 
                                                 TABLE-4 
QUANTIFICATION OF TABLET FORMULATION (NATRILAM) BY FIRST 
ORDER DERIVATIVE SPECTROSCOPIC METHOD 
*Mean of six observations 
 
 
 
Drug 
Sample 
No. 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab)* 
Percentage 
Obtained* 
Average 
(%) 
S.D 
% 
R.S.D. 
S.E. 
 
 
 
AML 
 
 
 
1 
2 
3 
4 
5 
6 
 
 
 
5 
 
4.91 
4.97 
4.97 
4.91 
4.91 
4.91 
 
98.20 
99.40 
99.40 
98.20 
98.20 
98.20 
 
 
 
98.60 
 
 
 
               
 
 
0.61967 
 
 
 
0.6247 
 
 
 
0.0172 
 
 
 
IND 
 
 
 
 
1 
2 
3 
4 
5 
6 
 
 
 
1.5 
 
1.49 
1.46 
1.49 
1.52 
1.49 
1.49 
 
99.33 
97.33 
99.33 
101.3 
99.33 
99.33 
 
 
 
99.325 
 
 
 
 
 
 
1.25544 
 
 
 
 
 
1.26398 
 
 
 
0.0348 
 
TABLE -5 
INTRA DAY AND INTER DAY ANALYSIS OF FORMULATION BY FIRST 
ORDER DERIVATIVE SPECTROSCOPIC METHOD 
Drug 
Sample 
No. 
Labeled 
amount 
(mg/tab) 
Percentage 
obtained* 
S.D % R.S.D. 
Intra 
day 
Inter 
day 
Intra 
day 
Inter 
day 
Intra 
day 
Inter 
day 
 
 
AML 
 
1 
2 
3 
 
 
5 
5 
5 
 
 
98.20 
98.20 
98.40 
 
98.20 
98.40 
98.20 
 
 
 
0.69282 
 
 
 
0.11547 
 
 
 
 
0.7026 
 
 
0.11751 
 
Mean 
 
98.26 
 
98.26 
 
 
 
IND 
 
 
1 
2 
3 
 
1.5 
1.5 
1.5 
 
99.33 
97.33 
99.33 
 
99.33 
97.33 
97.33 
 
 
1.15470 
 
 
1.1547 
 
 
1.1703 
 
 
1.17830 
 
MEAN 
 
98.66 
 
97.99 
 
*Mean of Three observations 
 
TABLE -6 
RUGGEDNESS STUDY BY DERIVATIVE SPECTROSCOPIC METHOD 
Drug Condition 
Average* 
% Obtained 
S.D 
% 
R.S.D 
S.E. 
 
 
 
AML 
 
 
 
Analyst 1 
Analyst 2 
 
Instrument 1 
 
 
98.33 
98.20 
 
98.33 
 
 
0.11547 
0.69282 
 
0.11547 
 
0.117427 
0.117830 
 
0.11742 
 
0.01283 
0.07698 
 
0.01283 
 
 
 
IND 
 
 
 
 
Analyst 1 
Analyst 2 
 
Instrument 1 
 
 
97.96 
97.80 
 
98.68 
 
1.1543701 
1.154701 
 
1.154701 
 
0.178306 
1.170344 
 
1.170344 
 
0.1183 
0.1283 
 
0.1283 
*Mean of Three observations            
 
TABLE-7 
RECOVERY STUDY DATA OF 50% PRE ANALYSED FORMULATION BY 
FIRST ORDER DERIVATIVE SPECTROSCOPIC METHOD 
 
Drug 
 
Amount 
present* 
(µg mL-1) 
 
 
Amount 
Added* 
(µg mL-1) 
 
 
Amount 
estimated* 
(µg mL-1) 
 
 
Amount 
recovered* 
(µg mL-1) 
 
% 
Recovery* 
(µg mL-1) 
S.D. 
% 
R.S.D. 
S.E. 
 
 
 
AML 
 
 
 
25 
25 
25 
25 
25 
25 
 
15 
22.5 
30 
37.5 
45 
52.5 
 
39.86 
47.15 
54.49 
61.84 
69.65 
76.94 
 
14.86 
22.15 
29.55 
36.83 
44.65 
51.94 
 
99.08 
98.14 
98.51 
98.26 
99.22 
98.94 
 
 
 
0.45061 
 
 
 
 
0.45659 
 
 
 
 
0.01251 
 
 
 
 
IND 
 
 
 
7.5 
7.5 
7.5 
7.5 
7.5 
7.5 
 
5 
7.5 
10 
12.5 
15 
17.5 
 
12.5 
14.96 
17.55 
19.96 
22.33 
24.95 
 
5.00 
7.47 
10.05 
12.46 
14.88 
17.46 
 
100.00 
99.73 
100.56 
99.76 
99.24 
99.79 
 
 
 
0.45296 
 
 
 
 
0.45350 
 
 
 
 
0.01258 
 
*Mean of Three observations            
 
TABLE-8 
OPTICAL CHARACTERISTICS OF AMLODIPINE BESYLATE AND 
INDAPAMIDE BY RP - HPLC 
PARAMETERS AMLODIPINE* INDAPAMIDE* 
max (nm) 240 240 
Beers law limit (μg mL-1) 80-120 24-36 
Correlation coefficient (r) 0.99993 0.99965594 
Régression équation 
(y=mx+c) 
Y= (34513.19)x+717.1428 Y=(70554.93)x- 
(-1552.982143) 
Slope (m) 34513.19 70554.93929 
Intercept (c) 717.1428 -1552.982143 
LOD (μg mL-1) 0.07491703 0.066817129 
LOQ (μg mL-1) 0.227021308 0.202476148 
Standard Error 3191.477 8481.610289 
 
*Mean of Three observations                                               
 
TABLE -9 
QUANTIFICATION OF TABLET FORMULATION (NATRILAM) 
BY RP-HPLC 
 
Drug 
Sample 
No. 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
Obtained* 
Average 
(%) 
S.D. 
% 
R.S.D. 
S.E. 
 
 
 
AML 
 
1 
2 
3 
4 
5 
6 
 
 
 
5 
 
5.082 
5.003 
5.057 
5.006 
5.077 
5.037 
 
101.65 
100.06 
101.14 
100.12 
101.54 
100.74 
 
 
 
100.86 
 
 
 
 
0.702332 
 
 
 
 
 
0.696309 
 
 
 
 
 
0.019509 
 
 
 
 
 
IND 
1 
2 
3 
4 
5 
6 
 
 
1.5 
1.506 
1.511 
1.508 
1.521 
1.508 
1.501 
100.40 
100.73 
100.53 
101.39 
100.57 
100.04 
 
 
100.61 
 
 
 
0.447169 
 
 
 
 
0.444458 
 
 
 
 
0.012421 
 
 
* Mean of six observations 
 
 
 
TABLE-10 
RECOVERY STUDIES OF AMLODIIPINE BESYLATE AND INDAPAMIDE 
BY RP-HPLC 
 
Drug Percentage 
 
Amount 
added* 
(µg mL-1) 
 
 
Amount 
recovered* 
(µg mL-1) 
 
% 
Recovery* S.D. 
% 
R.S.D. S.E. 
 
 
 
AML 
 
 
 
80 
 
100 
 
120 
 
80 
 
100 
 
120 
 
79.70 
 
99.47 
 
122.46 
 
99.53 
 
99.47 
 
102.04 
 
0.34219 
 
0.15821 
 
0.55018 
 
 
0.34389 
 
0.15905 
 
0.39182 
 
0.03802 
 
0.01758 
 
0.06113 
 
 
 
IND 
 
 
 
80 
 
100 
 
120 
 
 
 
24 
 
30 
 
36 
 
24.68 
 
29.63 
 
35.61 
 
102.55 
 
98.83 
 
99.26 
 
 
0.41061 
 
0.62601 
 
0.61808 
 
 
0.39995 
 
 0.63343 
 
0.62226 
 
 
0.04555 
 
0.06955 
 
0.06867 
 
*Mean of Three observations 
 
 
 
TABLE-11 
RUGGEDNESS STUDY BY RP-HPLC METHOD 
*Mean of Three observations 
 
 
 
 
Drug Condition 
 Average* 
% Obtained 
S.D % R.S.D S.E. 
 
 
AML 
 
 
Analyst 1 
 
Analyst 2 
 
99.82 
 
100.60 
 
0.141067 
 
0.752684 
 
0.141322 
 
0.74817 
 
0.141322 
 
0.083682 
 
 
IND 
 
 
Analyst 1 
 
Analyst 2 
 
101.22 
 
102.09 
 
0.563205 
 
1.25576 
 
0.556417 
 
1.230012 
 
0.06257 
 
1.39529 
TABLE - 12 
SYSTEM SUITABILITY TEST PARAMETERS FOR THE OPTIMIZED 
CHROMATOGRAM BY RP - HPLC 
PARAMETERS 
AMLODIPINE 
BESYLATE 
INDAPAMIDE 
 
LIMIT 
Tailing factor 1.25 1.38 ≤ 2 
Asymmetrical factor 1.36 1.61 ≤ 2 
Theoretical plates 6080.68 4481 > 2000 
Capacity factor 5.97 4.91 > 2.0 
Theoretical plate per unit 
Length 
243.22 426.48 
 
---- 
Resolution 6.0325 ≥2 
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